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I. INTRODUCTION
466 million people worldwide have a varying severity of hearing loss, of 
which 34 million are children. Hearing loss may have a genetic background, but it 
can come from complications at birth, possible infectious diseases, chronic ear 
infection; a side effect of medicines (i.e. ototoxicity), noise and aging. Up to 60% 
of the causes of hearing loss in childhood can be prevented and treated. Early 
diagnosis is essential. Treatment of people with hearing loss is much more cost 
effective than providing long-term financial support for those who are unable to run 
an independent lifestyle. Most treatment options offer better quality of life for 
people with hearing loss. People with hearing loss benefit from early identification, 
use of hearing aids, assistive devices such as cochlear implants captioning and sign 
language; and other forms of educational and social support [1].  
I.1. Cochlear implant 
In recent years, almost all severe types of hearing loss have 
been rehabilitated with an implantable hearing enhancement system [2-7]. 
Cochlear implants (CI) have been providing functional rehabilitation for decades 
in children and adults with severe functional hearing loss due to cochlear 
damage of various backgrounds [8]. The CI is a surgically, partially 
implanted, hearing aid. It stimulates the remaining working peripheral cells of 
the auditory nerve through a series of electrodes, directly in the lumen of the 
cochlea, acting as a hair cell prosthesis. [9,10] 
The operation principle of cochlear implants are as follows: the external 
speech processor converts the sounds of the environment into electrical signals, 
which are transmitted by the transmitter coil to the internal implant unit, which is 
located under the intact scalp. The electrical impulses then pass through a series of 
electrodes connected to the internal electronics, directly to the spiral ganglion cells 
and then through the central auditory pathway to the auditory cortex (Figure 1/A-
E). 
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Figure 1. Schematic structure and operation of the cochlear implant. The external speech processor 
(A) converts the sounds of the environment into electrical signals, which are transmitted by the
transmitter coil (B) to the internal implant unit (C) under the intact skin. Electrical impulses then
reach the auditory cortex directly through the electrode array (D) that is connected to the internal
electronics, directly to the spiral ganglion cells (E) and then along the central auditory nerve.
There are currently different trends in cochlear implant electrode design [11]. 
The manufacturers provide a variety of implant configurations including different 
receiver-stimulators, electrode arrays (e.g. straight or pre-curved, full-length or 
short) and sound processors to choose from. This can facilitate decision making on 
an individual basis. Further important aspects of implant design such as: proximity 
to the modiolus [13],[14], electrical current requirements [15][13], energy 
consumption, trauma to the cochlea [15], combined electro-acoustic stimulation 
[16][17], preservation of cochlear structures with low-trauma surgical technique 
[13],[18]-[20] and hearing preservation [21]-[24] have become the focus of many 
discussions and studies. For example, recent evidence suggests that speech 
discrimination is not improved by deep insertion, but it is significantly improved by 
perimodiolar position of the electrode [25]. 
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Studies in implanted recipient groups with multiple implant types are 
difficult to compare the influence of the implant electrode characteristics on 
outcomes in the presence of additional variables for example: implant electronics, 
sound processors and speech coding paradigms. Hence, to reduce the number of 
variables, comparison of the influence of the electrode designs on outcomes could 
be interpreted more effectively if a consistent receiver-stimulator design and a 
common sound processor are used. Recent publications [26-30] have shown 
imaging and electrophysiological results with CI532, but no comparative studies 
have yet been published. 
Our center’s postoperative radiological comparative study demonstrated that 
the Slim Modiolar electrode array took a closer position to the modiolus than the 
Contour Advance electrode array [(ref III, [31])]. 
I.2. Postoperative hearing preservation 
Since the CI’s launch, they have undergone significant technical 
advancement, necessitating the adaptation of surgical techniques from time to time. 
From the outset, efforts have been made to preserve the patient's residual hearing 
after surgery [32]. This concept was particularly prominent in all cases where the 
patient's low frequency hearing could be rehabilitated including cases with 
conventional hearing aids. However speech comprehension was accompanied by
acoustic amplification, due to the simultaneous presence of severe mid- and high-
tone loss representation, was almost impossible. This has led to the emergence of 
implant systems based on the principle of electro-acoustic stimulation (EAS), which 
use conventional acoustic amplification as well as implanted electrical stimulation 
[33]. The former provides amplification in the low frequency range, whilst the latter 
provides adequate stimulation in the higher frequency range to optimize the patient's 
speech intelligibility. 
Residual hearing sensitivity may deteriorate due to perioperative traumas or 
complications with delayed onset. The applied surgical approach (round window 
(RW), extended round window (ERW), and cochleostomy (CS)) and the implanted 
electrode profile mainly lead to immediate or short-term damage, while delayed 
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alteration in cochlear function usually derives from the fibrous or bony remodelling 
of the endocochlear compartments. 
Surgically important properties are: the physical attributes of the electrode 
configuration (perimodiolar vs. straight; rounded vs. smoothened tip; short vs. 
regular; with or without stylet, etc.), the type of cochlear fenestration (RW, ERW, 
CS), the method of electrode insertion (standard vs. soft surgery with advance-off-
stylet), the use of lubricants or drugs in the cochlea (e.g. hyaluronic acid, intrascalar 
corticosteroids) and the intrascalar position of the electrode array (perimodiolar, 
mid-scala, or lateral wall) [34,35],(ref.I.[36])]. 
However, the possible disproportion between the physical dimensions of the 
electrode profile and the endocochlear compartments (e.g. diameter, shape, length 
of scala tympani) also play a significant role in preserving inner ear structures and 
functions. 
Minimizing the damage in the inner ear enhances the possibility for hearing 
preservation, thus leads to better hearing performance. Systemic and/or 
intratympanic administration of steroids may contribute to hearing preservation. The 
beneficial effects of glucocorticoids are thought to be mediated through several 
different pathways: the anti-inflammatory effects; the down-regulation of 
production of inducible nitric-oxide synthase; and direct inhibition of the MAP/JNK 
cell death signal cascade [35]-[38],ref.I.] 
I.3. Cochlear™ Nucleus® CI500 Profile™ Series
Competing companies (Advanced Bionics, Cochlear, Med-El and Oticon, 
etc.) provide different types of receiver-stimulators, implant electrodes and speech 
processors. There are several pros and cons when opting for an electrode profile 
(straight or perimodiolar), cochlear coverage (total or partial), receiver-stimulator 
(physical attributes) and speech processor (electric or electroacoustic stimulation), 
to meet the individual needs. One of the primary aims of cochlear implant system 
engineering is to promote atraumatic electrode insertion, to maintain optimal 
postoperative hearing sensitivity, by protecting and preserving the delicate inner ear 
structures. 
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A critical aspect of the design is the dimensions of devices. Decreasing the 
size (thickness of implant body, diameter of electrode array) facilitates minimally 
invasive surgical techniques, as thin implants can be implanted without a bony well 
[34,35]. Most implantable hearing device manufacturers have aimed to decrease the 
thickness of their cochlear implants, the most ambitious change can be observed 
across the Cochlear™ Nucleus® Profile implant series. Before 2017, the latest 
Profile devices from Cochlear Ltd. (Sydney, Australia) had an ~ 50 % decrease in 
thickness compared to older Nucleus® Freedom devices.  
The Nucleus Profile cochlear implant series have a thin implant body profile 
that is beneficial especially for young patients. The Nucleus Profile family is 
available with precurved electrode arrays (Contour Advance CI512, Slim Modiolar 
CI532) and a straight electrode array (Slim Straight CI522) [41].  
The maximum thickness of the Nucleus Profile is 3.9 mm which makes it 
the thinnest cochlear implant body. There is no pedestal or pin for fixation. The 
added protection; reinforced silicone rubber surrounding the implant and titanium 
casing, the implant body is resistant to larger forces. The new design is symmetric, 
so it can be used either for the right or left ear. The reference and the stimulator 
electrode arrays leave the implant body side by side. Smooth external surface 
minimizes biofilm formation and reduce risk of infection [41].  
I.3.1. Cochlear™ Nucleus® Profile™ Contour Advance® (CI512)
CI532 device has a precurved perimodiolar electrode array. It has a diameter 
at the basal end of 0.8 mm and at the apical end of 0.5 mm (Figure 2.). Firstly, the 
electrode array is stabilized in a straight position with a metallic wire, and later, 
during the insertion the wire is held stable and the electrode array is more forward 
so that electrode array takes the perimodiolar position and the wire is removed (this 
is the so called advance off-stylet technique) [41]. (Figure 3.) 
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Figure 2. Cochlear Nucleus Profile Implant with Contour Advance Electrode CI512 [41] 
Figure 3. Cochlear Nucleus Contour Advance Electrode (CI512) for perimodiolar electrode 
insertion[41] 
I.3.2. Cochlear™ Nucleus® Profile™ with Slim Straight Electrode (CI522)
The CI522 system is equipped with a fully straight electrode array. The soft 
tip of the electrode array measures 0.3 mm in diameter at the apical end to minimize 
insertion trauma. The diameter at its basal end measures 0.6 mm (Figure 4.). Two 
white markers indicate the insertion depth range at 20 mm and 25 mm. The stiffener 
enables a smooth, single motion insertion to minimize insertion trauma. Handling 
and optimized lead angle for electrode orientation and ease of surgery due to the 
new design [41]. 
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Figure 4. Cochlear Nucleus Profile Implant with Slim Straight Electrode CI522 [41] 
I.3.3. Cochlear™ Nucleus® Profile™ with Slim Modiolar Electrode (CI532)
This new electrode array design has been built on 30 years of experience and 
has been developed in collaboration with CI surgeons. [41] 
Figure 5. Comparison of perimodiolar electrode arrays. The figure shows the dimensions of the 
Nucleus CI532 thin perimodiolar electrode profile and the CI512 Contour Advance electrode 
profile. [36] 
The CI532 is one of the thinnest electrode arrays and it is a full length 
perimodiolar electrode platform with 60% less volume than the CI512 (Figure 5.). 
This perimodiolar design makes the developed electrode array soft, flexible and 
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atraumatic. The distance from electrode tip to the most proximal electrode contact 
is 14.4 mm with a dimension at the basal end of 0.475 × 0.5 mm and at the apical 
end of 0.35 × 0.4 mm [41] (Figure 6.) 
Figure 6. Cochlear Nucleus Profile with Slim Modiolar Electrode (CI532) [41] 
I.3.4. Cochlear™ Nucleus® Profile™ Plus
Designed for 1.5 Tesla and high-resolution 3.0 Tesla MRI scans without the 
need to remove the magnet. The magnet can be removed if this is required to 
significantly reduce artifacts around the magnet (i.e MRI of the skull). The 
dimensions of new Profile Plus series are identical with their predecessors, only the 
magnet technology changed. [41] 
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II. OBJECTIVES
1. To compare the influence of various electrode designs upon selected
electrophysiological outcomes for cochlear implant recipients using the same model
of receiver- stimulator, Cochlear™ Nucleus® Profile Series and sound processor in
a retrospective study.
2. Postoperative preservation of residual hearing and the maximization of hearing
performance depends on minimizing the trauma during implantation of the electrode
array. To achieve this, minimal invasive methods and thinner, low-trauma electrode
arrays were required. Our aim is to monitor the possibility of postoperative acoustic
hearing preservation and demonstrate it in one special case.
3. To analyze statistical data of the registered long-term hearing preservation in a non-
randomized, prospective clinical cohort with specialized slim, perimodiolar
cochlear implant systems based on methods and results of above special case.
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III. MATERIALS AND METHODS
III.1. Electrophysiological measurements with Profile implant devices
The attributes of CI500 Profile family provide an opportunity to examine the 
practical value of such changes and allows us to assess the first experiences with the 
device from the user and the clinician perspective. 
III.1.1. Inclusion and allocation of subjects
A total of 139 consecutive subjects who were implanted between 13 June 
2014 and 4 May 2017 with a Profile CI532 (referred to as CI532), a Profile CI512 
(referred to as CI512), and a Profile CI522 (referred to as CI522) device 
manufactured by Cochlear Ltd., Australia and gave their informed consent were 
enrolled into this retrospective study from two tertiary referral implant centers 
(referred to as Department of Otorhinolaryngology, Albert Szent-Györgyi Clinical 
Center, University of Szeged, Hungary (Clinic 1) and Department of 
Otorhinolaryngology, Karl Landsteiner University Hospital of St. Pölten, Austria 
(Clinic 2)). Time periods of the study recruitment were from 13 June 2014 to 14 
December 2015 for CI512, from 13 November 2015 to 4 May 2017 for CI532, and 
11 March 2015 to 29 November 2016 for CI522. All subjects were examined with 
high resolution computed tomography (CT) and/or magnetic resonance imaging 
(MRI) before surgery. Exclusion criteria were cochlear malformations, cochlear 
otosclerosis, obliterative postmeningitis changes and electrode tip fold-over. To the 
authors knowledge there were no neural disorders in either group. Postoperative 
radiography was performed in each subject to confirm that the active electrode array 
occupied an intracochlear position with no complications or abnormal electrode 
position.  
The subjects were allocated into groups based on the electrode type 
implanted (Table 1). Those who received a CI532 formed group 532, those who 
received a CI512 formed group 512, and those who received a CI522 formed group 
522. Subjects were consecutively treated as part of routine clinical practice that was
comparable at each respective implant site. A total of 159 ears in 139 subjects were 
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implanted with devices, including the same implant receiver stimulator electronics. 
CI532 had an array with 22 electrode endpoints which was perimodiolar and with a 
relatively smaller diameter (named Slim Modiolar), CI512 had a 22 electrode array 
which was perimodiolar with a relatively larger diameter (named Contour Advance), 
and CI522 had a 22 electrode array which was straight, also with a relatively small 
diameter (named Slim Straight). 
Table 1. Subject demographics for each subject group. Note: For continuous variables, the mean 
and + 1 standard deviation are shown in brackets 
Subject group 532 512 522 
CI532 CI512 CI522 
Slim modiolar Contour Advance Slim straight 
46 45 48 
54 54 51 
25.17±26.29 20.80±25.87 55.36±28.59 
25/29 23/31 33/18 






Number of patients 
Number of ears 
Age (year±SD)
Sex (male|female no./ears ) 
Duration of deafness (year±SD)




Others 17% 25% 
A total of 54 ears were implanted with CI532 (all in Clinic 1), 54 ears with 
CI512 (51 in Clinic 1 and 3 in Clinic 2), and 51 ears with CI522 (47 in Clinic 2 and 
4 in Clinic 1). Patients who were implanted with CI532 formed the test group. Two 
control groups were formed from patients who were implanted with 512 and 522. 
The underlying causes of hearing loss were congenital, progressive, unknown and 
others (e.g. cholesteatoma, infection, Meniere’s disease, meningitis, ototoxic drugs, 
sudden hearing loss, trauma) in 29, 22, 16, and 33% for group 532, 28, 26, 28, and 







The electrode arrays were inserted into the cochlea according to the 
manufacturer’s instructions provided in the physician’s surgical guide. The method 
of electrode insertion was identical in both implant clinics [31]. Full insertion was 
achieved via the extended round window approach with CI532 and CI512 and via 
the round window approach with CI522 in all ears. The AOS (advance off-stylet) 
technique was used for CI512 and the freehand technique was used for CI522. 
Electrode choice was dependent on the type of implant availability for each center 
(regulated by the health authorities). The age of the patients did not influence 
implant choice. Discussion of hearing preservation was not an objective of this 
study. 
III.1.3. Electrophysiological testing
The three different types of electrode arrays were compared with regards to 
outcomes from intraoperative and 3-months postoperative electrophysiological 
testing performed as per routine clinical protocol (Table 2). Intraoperative 
electrophysiological tests were carried out as part of the regular fittings with Nucleus 
Custom Sound 4.4 software: impedance was measured for each electrode, the 
electrical stapedial reflex threshold (ESRT) with 25 μs pulse width for every second 
electrode contact (No. 2, 4, 6 etc.) and neural response telemetry threshold (T-NRT) 
for 6 (No. 2, 6, 10, 14, 18 and 22) electrode contacts. ESRT values were compared 
in groups 532 and 512. T-NRT values in group 532 were compared with those in 
both control groups. A common sound processor (Nucleus CP910) was used. The 
centers followed their normal routine protocol, thus the electrophysiological 
measurement protocol of the two centers was not identical, i.e. intraoperative ESRT 
testing, postoperative T-NRT measurements were not included in the routine 
protocol by Clinic 2, and CI522 was not analyzed with regards to these parameters. 
Furthermore, postoperative NRT cases were not measured for subjects in each 
group, where the current required to elicit a threshold response exceeded their 
discomfort or pain level. In every case first fitting was performed 4 weeks post-
surgery. In order to determine the electric threshold (T-levels), and comfort 
threshold (C-levels), the subjective fitting method was used in adults and the semi-
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objective NRT based fitting (based on the intraoperative T-NRT results) was applied 
in children [36,37]. Default MAP parameters (25 μs pulse width, 900 Hz stimulation 
rate and 8 maxima) were used. Postoperative NRT was measured 2 months after the 
first fitting, i.e. 3-months follow up. C-levels at first fitting and 3-months follow-up 
fitting and T-NRT at 3-months follow-up were compared. Outcomes for precurved 
slim perimodiolar electrode design, used at one implant clinic were compared to 
outcomes for two control groups of recipients implanted with precurved 
perimodiolar and straight electrodes in both implant clinics. Electrode designs were 
compared on the basis of outcomes for intraoperative objective electrophysiological 
measurements and postoperative threshold levels and comfort levels to characterize 
electrode position within the cochlea. 
Table 2. Summary of the intraoperative and postoperative evaluation protocols and available data 
sets for each type of electrode. The routine protocol in Clinic 2 did not include measurement of 
intraoperative ESRT, and postoperative T-NRT. 







intraoperative ESRT 44 47 0 
intraoperative T-NRT 50 47 43 
postoperative C-level (1 month) 54 54 51 
postoperative C-level (3 month) 54 54 51 
postoperative T-NRT (3 month) 32 36 0 
III.1.4. Statistical analysis
Statistical analysis with the Student’s t-test (P < 0.05) and one-way repeated 
measures ANOVA test were performed with 95% confidence interval (p < 0.05). 
Before the calculation, tests for normality of data distribution were performed. 
Bonferroni correction was used as needed to consider multiple variables (e.g. 
comparison of all three implant groups). The comparison was made on each 
electrode and all of the electrodes (Grand average). The tests were performed with 
Microsoft Excel 2016 and SPSS for Windows. 
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III.2. Possibility of postoperative preservation of residual hearing by CI532
with one case 
Several studies have shown the positive properties, location and dimensions 
of CI532 Slim Perimodiolar electrode, which provide the possibility of preserving 
residual hearing after implantation. There are some surgical techniques of 
approaching the scala tympani (i.e., RW, ERW, CS) with varying risks of harming 
the fine structures of the cochlea with prompt or delayed onset [49]. Such late 
complications, for example the appearance of endocochlear connective tissue or new 
bone formation, may lead to a gradual partial or complete loss of residual acoustic 
hearing [68]. This is most likely to be seen when the RW is extendedly exposed, 
where endothelial lesions trigger new tissue proliferation. The tendency to harm the 
endocochlear structures is decreased when minimally invasive, soft surgery is 
applied [49]. Physical attributes of the electrode profile may also interfere with 
postoperative cochlear function. Theoretically, the endocochlear hydrodynamics 
may also be altered, as the vibration of the basilar membrane is restricted due to the 
presence of an electrode array. At this point, as the travelling waves to the apical 
region are modified, the basilar membrane would react to sounds differently, which 
leads to an endocochlear “conductive” hearing loss [70],[71]. 
III.2.1. Nucleus CI532 Slim Modiolar electrode profile
Electrode profiles can be classified into the following categories 
perimodiolar, 'mid-scala' or 'lateral-wall'. Those are based on their distance from 
modiolus (Figure 7.) [27]. 
Figure 7. Grouping electrode profiles based on their distance from modiolus. Electrode profiles can 
be classified as (A) perimodiolar, (B) mid-scala, (C) lateral-wall. 
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The studied cochlear implant system has a slim, full-length (98 mm total 
length) perimodiolar electrode (Figure 8.).  
Figure 8. (A) Atraumatic electrode insertion in optimal position with the reloadable sheath. (B) Slim, 
perimodiolar electrode configuration with total insertion of the electrode array 
The electrode array is easy and smooth to insert through RW or CS with the 
guiding sheath that is the main handle assist tool and it is reloadable. The thin 
electrode array allows unobstructed access to the scala tympani that has a tip 
diameter of 0.35×0.4 mm and 0.45×0.5 mm at the base. At the last edge of the 
electrode array there are 3 white marker rings for controlling the insertion depth that 
are followed by 22 half banded platinum electrode contacts. These properties make 
this implant configuration easier to use with shorter incision and surgery time. The 
insertion assistant sheath platform and the physical attributes of the electrode array 
facilitate to approach the modiolus and thus prevent the electrode from dislocation 
into the scalae media or vestibuli. [29],[44] 
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Figure 9. Cochlear® Nucleus CI532 with Slim Modiolar electrode profile in the endocochlear 
location. The most common surgical gates for opening the inner ear. (A) The schematic diagram 
depicts the structure of the labyrinth, which clearly shows the electrode array (orange) introduced 
through the fenestra rotunda (black arrow). As an alternative surgical penetration, the location of 
the cochleostoma hole is indicated by a black star in the figure. The enlarged section on the right 
shows the microscopic sketch of the cochlea, showing the fluid spaces essential for successful 
implantation (ST - scala tympani; SV - scala vestibuli; DC - ductus cochlearis). 
(B) In relative cross-section view could be seen CI532 electrode array (orange solid, solid cross-
section) takes up to 60% less volume in scala tympani than the CI512 (orange, dashed outline)
electrode array
Due to the electrodes’ special, flexible three-dimensional (3D) conformation 
it can be located under the lamina spiralis ossea, ensuring that the stimulation points 
are near the spiral ganglion cells (Figure 9./B). Its atraumatic design ensures the 
preservation of endo-cochlear structures [45]. It has a unique insertion mechanism 
that allows the surgeon to choose the most appropriate approach depending on 
cochlear anatomy. For safety, the electrode has a reusable supporting tool (sheath), 
which significantly increases the chance of electrode location in optimal position 
[27]. 
III.2.2. Minimally invasive surgical technique
Preserving the residual hearing requires minimally invasive techniques of (1) 
cochlear fenestration, (2) management of endocochlear fluid compartments and (3) 
atraumatic electrode insertion, known as soft surgery. Thinner and atraumatic 
electrode arrays are also designed to accomplish these aims, as postoperative hearing 
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performance can be maximized by minimizing the insertion trauma [32],(ref.I., 
[36]), [44],[46],[47]. 
Several important factors contribute to intracochlear damage during 
implantation: (1) direct physical trauma, (2) pressure wave propagation in the 
perilymphatic fluid, (3) vibration and/or heat trauma from drilling, (4) loss of 
perilymph, (5) changes in homeostasis/hydrodynamics of the endocochlear fluid 
compartments, (6) delayed fibrotic changes and new bone formation within the 
cochlear lumen [(ref.I., [36]),[48]-[52]. 
The physical attributes (length and diameter) of the electrode array may each 
limit the postoperatively achieved residual hearing [53]. 
Comprehensive analysis of imaging diagnostics of the middle and inner ear 
provide indispensable information for planning the proper surgical access route and 
electrode [53],[54]. 
III.2.3. Soft surgery
The term soft surgery was introduced by Lehnhardt in 1993 and it provided 
basis for numerous publications [32],[55]  
Our routinely applied minimally invasive surgical technique involved 
electrode insertion via the Round Window (RW). In order to reduce bleeding and to 
prevent blood from accessing the cochlea, we filled the tympanic cavity with 
adrenaline solution after having completed the posterior tympanotomy. To prevent 
bone fragments entering the cochlea, the tympanic and mastoid cavity were flushed 
with abundant amount of saline. To remove the bony overhang of the round window, 
we used a 1 mm diamond burr at low speed (max. 350 rpm) in order to avoid noise 
and heat injury. Surgeon opened the RW membrane with a microscopic needle or
hook. After opening the inner ear, suction was applied with care in order to 
avoid the reduction of the amount of perilymph. Furthermore, the scala tympani 
was left open for the shortest possible period, to prevent bone fragments, blood or 
other substances entering the inner ear, which may lead to primary and/or 
secondary injuries and eventually loss of residual hearing. As a preventive 
measure, after having opened 
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the RW, we placed a piece of gel-foam soaked in corticosteroid solution into the 
RW niche. 
The slim modiolar electrode of the CI532 implant was soaked into 
methylprednisolone solution (40 mg powder dissolved in 10 ml saline) and it was 
retracted into the insertion sheath. The insertion sheath together with the electrode 
array was inserted into the scala tympani with the lowest possible force. Any minute 
resistance felt by the surgeon would have indicated physical contact of the electrode 
array to the basilar membrane or the lateral wall of the scala tympani or stria 
vascularis resulting in possible injury of these structures. After the electrode had 
been inserted in full length, indicated by the 1st marker ring, the RW was 
immediately sealed with an autologous tissue (e.g. fascia or muscle) in order to 
prevent loss of perilymph [32]. 
III.2.4. Patient data
Our female patient was born in 1987. Due to her congenital loss of hearing, 
she has been wearing conventional air-conductive hearing aids on both ears since 
childhood. 6 months prior to cochlear implantation, she had pronounced progression 
in her hearing loss on both sides, therefore she did not have sufficient speech 
comprehension ability even when wearing her hearing aids. The implantation was 
evaluated by detailed audiological and radiological tests.  
Subsequently, the implantation was performed when the patient turned 30, 
under general anesthesia. Since the patient had residual hearing on both ears prior 
to surgery, we decided to use a thin perimodiolar electrode profile (CI532 Slim 
Modiolar implant). The operation was performed on the patient's right ear using the 
minimally invasive surgical technique described above via the RW. 
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III.3. Long-term postoperative hearing preservation with CI532
In our previous series of case, we performed audiological measurements on 
a larger group of successes that could demonstrate the atraumatic effect of CI532. 
Table 3. Population of study patients. 
No. Gender Age (year) Implanted ear Hearing Loss 
w/wo genetic 
origin 
Total Hearing Loss 
(THL) after 
implantation 
1 Male 55 Left No No 
2 Male 59 Left Yes Yes 
3 Male 16 Right No No 
4 Male 24 Right No No 
5 Male 15 Left No Yes 
6 Male 72 Right No No 
7 Female 70 Right No No 
8 Female 71 Left No No 
9 Female 10 Right Yes Yes 
10 Male 11 Right No No 
11 Female 43 Left Yes Yes 
12 Female 28 Right No No 
13 Female 28 Left No No 
14 Female 11 Right No No 
15 Female 70 Right No No 
16 Female 24 Right No No 
17 Male 62 Right No No 
18 Female 77 Right No No 
19 Female 42 Right No No 
20 Female 48 Right No Yes 
21 Female 71 Left No No 
22 Female 53 Right No Yes 
23 Female 59 Right No No 
24 Male 13 Right No No 
25 Female 27 Right No No 
26 Female 35 Left No Yes 
27 Female 59 Left No No 
28 Female 30 Right No No 
29 Male 53 Right No No 














Out of the total number of cochlear implantees with slim perimodiolar 
implant system (n=94) our study population was recruited on the basis of the 
following criteria: (1) patient with good compliance; (2) measurable preoperative 
hearing threshold; (3) slim perimodiolar electrode array implant system; (4) 
minimum one-year follow-up period.  
30 consecutive subjects were enrolled into this prospective, non-randomized 
clinical study. 20 females and 10 males with mean age at implantation of 43.32 
years, ranged between 10 years to 77 years. All subjects were implanted at the 
University of Szeged from 2015 - 2017. The postoperative follow-up duration lasted 
1.72 years on average (ranging between 1.1 and 2.55 years). All subjects met 
the official indication criteria of cochlear implantation. Anatomical or
structural malformation was not revealed by the preoperative radiological 
examinations. For detailed patient data, please see Table 3.  
III.3.2. Radiological validation
Radiography (skull AP axial/Towne view) was performed on the first 
postoperative day to confirm the proper intracochlear electrode position (Figure 10). 
Figure 10. Skull AP axial on the first postoperative day confirms the proper in situ electrode position. 
The depicted subject (not included in the present study due to completely missing preoperative 
hearing) was chosen to interpret the differences between sequentially implanted systems (A: right 
ear: CI512 Contour Advanced; B: left ear: CI532 Slim Perimodiolar). A decreased electrode array 
curvature is seen with the slim perimodiolar system (B). 
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III.3.3. Pure-tone audiometry
Pure-tone air-conduction thresholds were used to register residual hearing 
using the ascending method, with 5 dBHL intensity steps. The audiometer (GSI 61 
Clinical Audiometer; Grason-Stadler, MN USA) was calibrated according to the 
standards of the International Organization for Standardization (ISO 389-1:2017). 
THD-50P (Telephonics Corporation/Griffon Company, NY USA) headphone was 
used for air conduction hearing measurements. 
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IV. RESULTS
All subjects received Nucleus Profile implants. The only difference was the 
type of electrode. The patient groups were similar in subject numbers, etiology, 
duration of deafness, and indications. 
IV.1. Electrophysiology testing
The electrophysiology testing: Intraoperative and postoperative measurements 
IV.1.1. Intraoperative measurements
Firstly, intraoperative electrical stapedial reflex threshold (ESRT, Figure 11) 
and Neural Response Telemetry (T-NRT, Figure 12), results were compared across 
implant groups. The stapedial reflex was tested in all subjects in group 532 and 512 
and could be elicited in 44 out of 54 cases in group 532 and in 47 out of 54 cases in 
the control group (group 512). Figure 11 shows that the mean ESRTs were lower in 
group 532 than in group 512. This difference was significant (t probe: p = 0.007) for 
electrode contact 2. Grand average (all electrodes) statistic calculation (Grand T532–
512) showed significant differences between groups 532 and 512 (p < 0.05).
Figure 11. The mean intraoperative ESRT values in patient groups with different types of CIs: group 
532 (n = 44) and group 512 (n = 47). The “+” means a significant difference between groups (a) 
and (b). Error bars stand for the standard deviation (SD). „A” stands for Nucleus CI532 and „B″ 
for Nucleus CI512 implants. Grand T532–512 means statistical comparison between groups 532 
and 512. cu -"current unit" represent the current amplitude of programming stimulus at the 
specified pulse width.
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Figure 12. Intraoperative T-NRT values in all groups: Groups 532 (n = 50), 512 (n = 47) and 522 
(n = 43). The “+” stands for significant difference between groups 532 and 512. The “*” represents 
a significant difference between groups 532 and 522. The error bars represent the standard deviation 
(SD). The mean NRTs proved to be lower in each electrode in group 532 when compared with both 
control groups. The difference was significant in 5 measured electrodes when compared with 522 
and 3 measured electrodes when compared with 532 (t-probe: p < 0.05). Grand T532–512 means 
statistical comparison between groups 532 and 512. Grand T532–522 means statistical comparison 
between groups 532 and 522. 
Intraoperative NRT measurements were performed in all three groups. The 
neural response threshold was tested in all subjects and could be elicited in 50 out 
of 54 (group 532), 47 out of 54 (group 512), and 43 out of 51 (group 522) cases. 
Repeated ANOVA analysis revealed significant difference (p < 0.05) between the 
three groups. On examining the significance in pairs, we found that the mean T-
NRTs (Figure 12) proved to be lower in each electrode in group 532 when compared 
with each control group. The difference was significant in 5 measured electrode 
contacts when compared with CI522 and 3 measured electrode contacts when 
compared with CI512 (t-probe: p < 0.05). Grand average (all electrodes) statistic 
calculation (Grand T532–512 and Grand T532–522) showed significantly lower T-NRT 
values in group 532 compared with the two control groups (p < 0.05). 
IV.1.2. Postoperative C-levels
The subjects were scheduled for the first fitting 4 weeks after surgery. C-
levels during the first fitting were compared in patient groups with different implants 
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(Figure 13). No significant difference in mean C-levels was seen on any electrodes 
between groups 532 and 512, but grand average (all electrodes) statistic calculation 
(Grand T532–512) showed significant differences between the two groups (p < 0.05). 
C-levels were considerably higher on every electrode in group 522 compared to
groups 532 and 512, and the difference was significant for apical electrodes 2 to 12 
(p < 0.05, Figure 13.A). Grand average (all electrodes) statistic calculation (Grand 
T532–522) showed significant differences between the groups (p < 0.05). However, no 
significant difference was present on any electrodes in C-levels 2 months after the 
first fitting, only the grand average statistical analysis (Grand T532–522) showed 
significant differences between groups 532 and 522 (Figure 13.B). 
Figure 13. The mean postoperative C-levels in patient groups with different types of CI: Group 532 
(n = 54, n = 54), group 512 (n = 54, n = 54) and group 522 (n = 51, n = 51) at first fitting (A) and 2-
month follow-up fitting (B). The “*” stands for a significant difference between groups 532 and 522. 
Error bars represent the standard deviation (SD). Grand T532–512 means statistical comparison 
between groups 532 and 512. Grand T532–512 means statistical comparison between groups 532 
and 522 
IV.1.3. Postoperative T-NRT
In groups 532 and 512, T-NRT measurements were attempted in all subjects 
at the two-month follow up fitting and the measurements were successfully carried 
out in 32 subjects in group 532 and 36 subjects in group 512. The intraoperative 
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electrophysiological measurements could be performed in all subjects under general 
anesthesia, whereas the postoperative measurements were performed in vigil 
subjects. In the latter case, some of the subjects complained about unpleasant sound 
volume before a neural response could be measured, for this reason the 
electrophysiological testing could not be performed. 
Figure 14. The mean postoperative T-NRT values in subject groups with CI532 (n = 32) and CI512 
(n = 36). The „+” represents a significant difference between groups 532 and 512. Error bars 
represent the standard deviation (SD). Grand T532–512 means statistical comparison between 
groups 532 and 512 
Figure 14 shows the postoperative mean T-NRT values. The mean T-NRT 
results in the basal section were lower in group 532 than in group 512. The 
difference was significant (p < 0.05) on two electrodes (No 14 and No 16). Grand 
average (all electrodes) statistic calculation (Grand T532–512) showed significant 
differences between the groups (p < 0.05). 
IV.2. Hearing Preservation after Cochlear Implantation in one subject
Preoperative and postoperative hearing diagnostics consisted of complete 
subjective and objective tests. 
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IV.2.1. Preoperative hearing tests
The pure-tone threshold audiometry performed at speech frequencies (0.25 
to 1.0 kHz) showed a hearing threshold of 83,33 dBHL (Figure 15/A), while
speech understanding hearing test was not possible to perform due to the poor 
thresholds.  
Figure 15. Pre-and postoperative Pure-tone Threshold audiometry results. The implantation was 
done on right ear (red curves); the opposite side hearing is indicated by a blue curve. Preoperative 
Pure-tone Threshold Audiometry at speech frequencies (0.25 to 1.0 kHz) demonstrated an average 
hearing threshold of 83.33 dBHL (A). During the 4th Postoperative Week, we registered
hearing threshold decreasing in terms of speech frequency range at 0.25 to 1.0 kHz 5-10 dBHL and 
20 - 25 dBHL at 2.0 to 4.0 kHz (B). In 6th week Hearing threshold 1 kHz showed progression again 
(C), but the postoperative 12th month was an improvement, we measured similar hearing thresholds 
than in the 4th week (D). In the 6th month hearing threshold test demonstrated close to a social 
hearing threshold with an average hearing threshold of 35 to 40 dBHL with a cochlear implant on 
the right ear. In postoperative 12th month free field audiometry test showed better hearing threshold 
with CI as an average of 25 - 30 dBHL. 
Nominations: – X – = left air conductive Hearing threshold; – O – = opposite side air conductive 
hearing threshold; – Δ – = with CI hearing threshold in free field 
The objective tests were performed with normal middle ear ventilation 
(normal, type A tympanogram, on both sides). By measuring distortion product 
A              B
C D
33 
otoacoustic emissions (DPOAE), no external hair cell activity was registered on 
either side, which confirms the origin of sensorineural hearing loss in the inner ear. 
With a brainstem electric response audiometry test (BERA), we have registered with 
high intensity measuring low amplitude and reproducible responses with normal 
latency, which is also in favour of problems in the organ of Corti. In the brain stem 
section, no signs of neural involvement were seen (so-called retrocochlear lesion). 
At the Auditory Steady-State Response test (ASSRs), objective hearing threshold 
was estimated to severe degrees on both sides (Figure 16). 
Figure 16. Preoperative objective hearing thresholds on the right and left. The hearing threshold 
on the right (A) is 80 - 90 dB corHL, while on the left (B) is 90 to 100 dB corHL. The residual 
hearing at 500 Hz on the left is relatively spared. (corHL: sound intensity correction factor, 
reflecting the age of the patient and the conditions of recording) 
According to our results, the patient had a certain degree of residual hearing, 
but this would not have been sufficiently rehabilitated with conventional air-
conductive hearing aids. The objective tests did not raise concern of a cochlear nerve 
damage (retrocochlear lesion), and such a contraindication of cochlear implant was 
also excluded by the preoperative MRI scan. An internal ear malformation was not 
detectable. 
The patient met the audiological and radiological criteria of cochlear 
implantation, therefore surgery was recommended. 
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IV.2.2. Postoperative hearing tests
The first control measurement, as pure-tone hearing threshold test, was in 
the 4th postoperative week (Figure 15/B). A 5-10 dBHL threshold decrease was 
registered in the range of speech frequencies, at 0.25-1.0 kHz. At 2.0 to 4.0 kHz, 
we experienced 20-25 dBHL loss.  
Further hearing tests were performed in the 6th and 12th month after 
implantation. The registered hearing threshold in the 6th month showed progression 
above 1 kHz (Figure 15/C), but in the postoperative 12th month (Figure 15/D), after 
improvement, hearing thresholds were the same as in the 4th month. The 
postoperative tests were done with pure tone audiometry, whilst the speech 
processor of the cochlear implant was turned off. 
IV.2.3. Electrophysiology
The Nucleus CI532 is equipped with a perimodiolar electrode array that has 
22 channels. The impedance measurements that were made parallel with the 
postoperative pure tone audiometries show a number of fluctuations on 
some electrodes. Firstly, the 10th —22nd  electrode range became relative stable in 
the sixth month, while the electrodes 1-9 became stable  in the twelfth month 
(Figure 17), which may indicate the proper integration of the electrode 
array, inner ear homeostasis. 
Figure 17. Postoperative electrode impedance changes. On the top axis of the chart, the average of 
frequency range of different electrodes is indicated 
Nominations: -●– = postoperative 4th week; –▲– = postoperative 6th month; –■– = postoperative 
12th Month 
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IV.3. Results of Hearing Preservation cohort
Pre- and postoperative pure tone hearing threshold measurements were 
completed for all of the 30 recruited subjects. Figure 18 frequency-dependently 
illustrates the number of patients pre- and postoperatively, where hearing sensitivity 
was measurable. It is well demonstrated that hearing is the most stable within the 
250 to 1000 Hz range, and the least is beyond 4 kHz. This statement is true either 
pre- or postoperatively. 
Figure 18. Number of implantees with measurable hearing threshold at different frequencies. 
Preoperative (striped pattern columns); postoperative (checked pattern columns). On the top 
horizontal axis, the frequency-specific success rate of hearing preservation is presented in
percentages. 
The average preoperative thresholds of the hearing within the lower 
frequency range were 61.75 dBHL at 125 Hz (no response from 10 patients); 78.52 
dBHL at 250 Hz (no response from 3 patients). At the middle frequency range, 
mean values were 88.67 dBHL at 500 Hz (response from all patients); 97.07 dBHL 
at 1 kHz (no response from 1 patient) and 100.50 dBHL at 2 kHz (no response 
from 10 patients). At the higher frequencies, the average values were 91.36 dBHL 
at 4 kHz (no response from 19 patients) and 84.00 dBHL at 8 kHz (no response 
from 25 patients).  
The difference in height between the striped and checked pattern columns 
represents the percentage of successful hearing preservation at specific 
frequencies. 
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Figure 19. Preoperative (striped pattern columns) and postoperative (dotted pattern columns) 
hearing thresholds in dBHL at the measured frequencies (*p<0.05). 
One year postoperatively the average values of the hearing thresholds at the 
lower frequency range were: 93.89 dBHL at 125 Hz (no response from 17 patients); 
87.86 dBHL at 250 Hz (no response from 10 patients). At the middle frequencies 
mean values were 102.86 dBHL at 500 Hz (no response from 10 patients); 111.61 
dBHL at 1 kHz (no response from 14 patients) and 113.75 dBHL at 2 kHz (no 
response from 21 patients). At the higher frequencies, average values were 115.18 
dBHL at 4 kHz (no response from 24 patients) and 99.29 dBHL at 8 kHz (no 
response from 29 patients). Figure 19 illustrates the preoperative (striped pattern 
columns) and the postoperative (dotted pattern columns) hearing thresholds in 
dBHL at the measured frequencies. A decrease was detected at each examined 
frequencies but the grade of it varied. The highest decrease was measured at 500 Hz 
with an average decrease of 14.19 dBHL and at 1000 Hz with an average decrease 
of 13.77 dBHL. At the lower frequency range, hearing remained substantially stable. 
At 125 Hz only 3.06 dBHL, while at 250 Hz only 7.19 dBHL loss was detected. At 
the high frequencies, from 2 to 8 kHz preoperative hearing sensitivity had been 
already proved to be rather poor, thus further loss had just little consequences.  
n=12 n=18 n=20 *n=16  n=9 n=6 n=1 
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Figure 20. Loss of acoustic sensitivity interpreted in dBHL ranges, while exhibiting the number of 
implantees frequency-specifically (with different patterns of columns). 
Figure 20 frequency-specifically demonstrates the degree of loss of acoustic 
sensitivity grouped into dBHL ranges, whilst exhibiting the number of implantees. 
It is clearly shown that only minute threshold decay with less than 5 dBHL loss is 
the most frequently found, while prominent postoperative loss of hearing appears 
less often.  
IV.3.1. Subjects with complete loss of hearing following surgery
9 implantees (9/30=30%) showed up with total loss of residual hearing at 
every measured frequency following the surgery. Their preoperative hearing 
sensitivity is presented in Figure 21. It is clearly seen that within this subgroup of 
this cohort the measured average hearing threshold have been already poorer prior 
to surgery compared to those with preserved hearing. Genetic screening of the 30 
recruited subjects revealed mutations in three cases in the background of hearing 
loss. All of these subjects suffered complete hearing loss postoperatively 
(3/3=100%), therefore genetic alteration may serve as a predictor when opting for 
an electro-acoustic/hybrid device, should be taken into consideration when 
indicating these systems [25]. 
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Figure 21. Preoperative threshold of HP (striped pattern columns, n=number of patients) and THL 




V.1. Electrophysiological measurements with different types of perimodiolar
electrode array
A wide range of cochlear implants with different electrodes are available for 
rehabilitation of hearing-impaired patients with severe to profound sensorineural 
hearing loss. Hearing rehabilitation outcomes may be influenced by optimizing 
device and electrode choice for the individual. Several comparative studies have 
been conducted including electrophysiological (ESRT, NRT) test methods to 
evaluate the influence of straight and perimodiolar electrode designs and their in-
situ characteristics on clinical outcomes [11-13],[55-57]. Our study is unique in 
that it measured the influence of various electrode designs combined with a common 
receiver-stimulator alongside electrophysiological assessments for a relatively large 
routinely treated multicenter study cohort. As such, it is the first study to report on 
the influence of electrode design while using consistent implant receiver-stimulator 
electronics. The cooperation of Department of Otorhinolaryngology, University of 
Szeged, Hungary and Department of Otorhinolaryngology, Karl Landsteiner 
University Hospital of St. Pölten, Austria the was established in 2017 with the aim 
to compare the perimodiolar and the straight electrode arrays. The study clinics 
followed a standard protocol enabled by the manufacturer’s software, thus a 
conclusion from their individual results can be made. The results of Hey et al. from 
their multicenter study on CI532 are in good correlation with our results which 
proves that our methodology and results are reliable [30]. 
The Contour Electrode was the first perimodiolar electrode from Cochlear. 
As reported by researchers, some intracochlear trauma has been associated with its 
insertion, with a more reliable and less traumatic insertion achieved when deployed 
using the recommended advance off-stylet technique [13]. This is largely due to an 
inherent reduction in intracochlear outer wall force generation when using this 
technique for this electrode [13]. 
The Slim Modiolar Electrode is designed for insertion with minimal cochlear 
trauma. It has the advantage of taking 60% less volume in the scala tympani 
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compared to the Contour Advance Electrode and is therefore placed in a position 
close to the modiolus. Perimodiolar proximity is an important clinical consideration 
as Holden et al. [20] concluded, observing that total insertion depth was not 
associated with better speech discrimination outcomes, however, the distance from 
the electrodes to the modiolus did indicate a significant influence. The Slim 
Modiolar electrode array takes a closer position to the modiolus than the Contour 
Advance electrode array as confirmed by a comparative radiological evaluation 
[31]. 
In this retrospective study the data from recipients with the three main types 
of electrode arrays used in each of the two author implant centers were included. 
Although the electrode of CI522 was known to take the lateral wall position within 
the cochlea, the authors’ decided to enroll those subjects who were implanted with 
CI522 to gain a more detailed overview. Although results of two different implant 
centers were combined for evaluation, upon review, the authors considered the 
routine clinical practices employed and device parameters used at each site as 
sufficiently comparable. 
Results from the objective intraoperative measurements indicated that the 
electrode contacts of the CI532 array were located closer to the modiolus than those 
of CI512. A previous study found that withdrawal of the stylet in the Contour 
Advance Electrode resulted in better NRT and ESRT responses, than with the stylet 
in place. They concluded that this is most probably due to a more favorable position 
of the electrode array towards the modiolus within the scala tympani once the stylet 
is removed [51]. In our study, although the mean ESRT was only slightly lower with 
CI532, the difference was statistically significant at the basal most electrodes tested. 
However, the mean T-NRT for CI532 was significantly lower than for CI512, 
especially in the apical-middle section, which is considered to be indicative of closer 
positioning towards the modiolus. An expected rate of scalar dislocations could be 
26% with precurved electrode (i.e. CI512) and 3% with straight electrode (i.e. 
CI522) with round window insertion technique [58] and this dislocation should have 
a significant impact on the NRT threshold in the apical part of the electrode. In order 
to minimize scalar dislocation, the ERW insertion technique was used. Although the 
regular institutional protocols did not include postoperative computed tomography, 
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the results from T-NRT and ESRT, both being constantly higher for CI512 when 
compared with CI532 and T-NRT being constantly lower for CI512 when compared 
with CI522 are not indicative of significant dislocations between scalae tympani and 
vestibuli. The sizeable reduction in both T-NRT and ESRT observed in our study 
are considered sufficiently large to potentially influence differences in clinical 
outcomes as observed for subjective comfort level [56],[59]. 
The surface area of an electrode is inversely proportional with the resistance 
and therefore current is proportional with the surface area. If the electrode with a 
smaller surface is capable of eliciting the same response it means that it is closer to 
the stimulated structure. The lower objective electrophysiological thresholds of 
CI532 suggest that the electrodes are capable of eliciting reflex responses with lower 
stimulation intensity, resulting from closer proximity to the modiolus. 
V.2. Hearing Preservation
Preservation of acoustic hearing associated with cochlear implantation
improves the postoperatively achievable periodicity and spectral resolution, which 
improves the patient's speech comprehension and the localization of the tone in 
particularly difficult conditions [60]-[65] 
The effects of cochlear implantation on residual hearing have been discussed 
in several studies in which a number of surgical and technical factors have been 
identified [66]. There are some surgical techniques of approaching the scala tympani 
(i.e. RW, ERW, CS) with varying risks of harming the fine structures of the cochlea 
with prompt or delayed onset [48]. Late complications, such as the appearance of 
endocochlear connective tissue or new bone formation, may lead to a gradual partial 
or complete loss of residual acoustic hearing [67]. This is most likely to be seen 
when the RW is extendedly exposed, where endothelial lesions trigger new tissue 
proliferation. The slightest is the tendency to harm the endocochlear structures when 
minimally invasive, soft surgery is applied [48]. 
Physical attributes of the electrode profile may also interfere with 
postoperative cochlear function. Theoretically, the endocochlear hydrodynamics 
may also be altered, as the vibration of the basilar membrane is restricted due to the 
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presence of an electrode array. At this point, as the traveling waves to the apical 
region are modified, the basilar membrane would react to sounds differently, 
leading to an endocochlear “conductive” hearing loss [68,69]. 
The new type of thin-diameter electrode arrays close to the modiolus are 
expected to have a lower hydrodynamic load, since the bony spiral lamina is 
attached from below, thus the basilar membrane vibrations remain unrestricted. 
However, the perimodiolar position of the electrode array allows the adjacent nerve 
elements of the spiral ganglion to be stimulated with a lower electrical intensity and 
through a smaller surface. 
Cadaver experiments demonstrated that a force, applied to the basilar 
membrane with an average of 88mN (42-122 mN) would be sufficient to accomplish 
the interscalar dislocation of the electrode, of which manual perceptibility is 
questionable [70]. Studies with large case numbers (n = 100) have shown that the 
probability of the electrode line being located in the scala vestibuli significantly 
increased during CS, which also manifested itself in the absence of improvement in 
speech comprehension [71]. 
In a number of studies, intraoperatively performed electro-cochleography is 
used to track the electrode insertional trauma, furthermore to postoperative 
residual hearing follow-ups [72-74].
For the implementation of electro-acoustic (EAS) or hybrid speech processors the 
long-term preservation of residual acoustic hearing is inherently inevitable, thus 
application of atraumatic surgical techniques and electrode arrays is essential. 
Our study cohort demonstrates that by the application of appropriate soft surgery 
techniques and atraumatic electrodes are able to retain residual hearing on a long 
run. The positive experience gained with the new type of CI532 Slim Modiolar 
electrode predicts the possibility for the preservation of structural and functional 
integrity of all cochlear regions. Furthermore, a prompt, definitive solution could be 
provided for a possible late hearing loss progression, where only a psychophysical 
reprogramming of the implant would be enough. 
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On the basis of our results, if the acoustic hearing loss can be preserved with 
the assurance and efficacy of the initial experience, we will be able to provide 
sustained prominent hearing rehabilitation even in the indication of EAS that results 
in significant improvement in the life quality of many implantees. 
In addition, long-term residual hearing preservation follow-up could be of 
crucial importance in the subsequent feasibility of regenerative procedures and 
medical treatments [27,(ref. I., [36]) ,77,78]. 
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VI. CONCLUSION AND NEW RESULTS
Although the Slim Modiolar electrode is significantly thinner than the 
Contour Advance and similar sized as the Slim Straight electrode array, the Slim 
Modiolar electrode provides similar or better stimulation productivity compared to 
Contour Advance and Slim Straight electrodes. The manufacturer’s thinnest 
electrode array, the Slim Modiolar Electrode takes the position that is closer to the 
modiolus compared to the Contour Advance Electrode and the Slim Straight 
Electrode. Our intraoperative and postoperative measurements confirmed this 
showing that more effective stimulation can be achieved through the use of the Slim 
Modiolar Electrode.  
In cochlear implantation, the use of new electrode array could play a 
fundamental role in minimally invasive soft surgery, taking into individual needs, 
and providing long-term acoustic hearing preservation. Our study demonstrates the 
efficacy of the Nucleus CI532 Slim Modiolar electrode profile. It has the potential 
to preserve residual hearing, which predicts the possible use of this configuration as 
part of EAS systems, and it maintains the structures availability for future 
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A hallássérült betegek rehabilitációjában alkalmazott cochlearis implantáció során a residualis hallás posztoperatív 
megőrzése és a hallási teljesítmény maximalizálása az elektródaprofil implantációjakor kialakult trauma minimalizálá-
sától függ. Ennek megvalósításához minimálinvazív módszerek, továbbá vékonyabb, atraumatikus elektródasorok 
alkalmazására volt szükség. Célunk a posztoperatív akusztikai hallásmaradvány-megőrzés lehetőségének audiológiai 
nyomon követése volt. Betegünk veleszületett halláscsökkenése miatt gyermekkora óta hagyományos, légvezetéses 
hallásjavító készüléket viselt mindkét fülén. A cochlearis implantációt 6 hónappal megelőzően halláscsökkenésében 
mindkét oldalon kifejezett progressziót mértünk, ezért cochlearis implantátum beültetése mellett döntöttünk. A be-
teg a műtétet megelőzően mindkét fülén rendelkezett residualis hallással, ezért Cochlear® Nucleus CI532 Slim 
Modiolar implantátumot alkalmaztunk. A minimálisan invazív műtétet a beteg jobb fülén végeztük el kerekablak-
behatoláson keresztül. A preoperatív hallásküszöbhöz (átlag 85 dBHL) viszonyítva a 4. posztoperatív héten 0,25–1,0 
kHz között 5–10 dBHL, míg 2,0–4,0 kHz-en 20–25 dBHL mértékű iniciális hallásküszöbromlást tapasztaltunk. 
A 6. hónapban mért hallásküszöb az 1 kHz feletti tartományban további kisfokú progressziót mutatott, ugyanakkor 
a 12. hónapban a hallásküszöb javult, a 4. héten kapott eredményekkel megegyezett. A cochlearis implantáció resi-
dualis hallásra gyakorolt hatásait több tanulmány is vizsgálta, melyekben számos sebészi és technikai tényező kulcs-
szerepét meghatározták. A CI532 Slim Modiolar eletródaprofil modiolushoz közeli elhelyezkedése várhatóan kisebb 
endocochlearis hidrodinamikai terhelést jelent, mindemellett lehetővé teszi, hogy a ganglion spirale szomszédos 
idegelemeit alacsonyabb áramintenzitással, kisebb felületen ingerelhessük, ami neuroprotektív hatású lehet. Az akusz-
tikai hallásmaradvány cochlearis implantáció kapcsán történő megőrzése javítja a beteg beszédértését és hanglokalizá-
ciós képességét, különösen nehezített körülmények között. A residualis hallás hosszú távú megőrzése kiemelkedő 
fontosságúnak bizonyulhat továbbá a későbbi regeneratív eljárások, gyógyszeres kezelések megvalósíthatósága kap-
csán is.
Orv Hetil. 2018; 159(41): 1680–1688.
Kulcsszavak: cochlearis implantátum, CI532 Slim Modiolar elektróda, maradványhallás-megőrzés, minimálinvazív 
sebészet
Possibilities for residual hearing preservation with Nucleus CI532  
Slim Modiolar electrode array 
Case report
During the rehabilitation of hearing-impaired patients, the preservation of residual acoustic hearing following coch-
lear implantation by minimizing the implantation trauma allows for improved hearing performance. To achieve this, 
minimally invasive, soft surgery methods and thinner, atraumatic electrodes were required. In our present study, we 
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reported a case where Cochlear® Nucleus CI532 Slim Modiolar electrode was implanted in a patient with residual 
hearing. Our aim was to study the possible preservation of postoperative acoustic residual hearing by audiological 
monitoring. Since childhood, due to her congenital hearing loss, she has been wearing a conventional, airborne hear-
ing correction device on both ears. Six months before cochlear implantation, we measured the progression on both 
sides of the hearing loss, so we decided to perform cochlear implantation. The patient had residual hearing on both 
ears prior to surgery thus the Cochlear® Nucleus CI532 Slim Modiolar Implant was used. The minimally invasive 
surgery was performed on the patient’s right ear through the round window approach. Compared to the preopera-
tive hearing threshold (average 85 dBHL) in the 4th postoperative week, an initial hearing threshold progression of 
20–25 dBHL was observed between 0.25 and 1.0 kHz, while of 5–10 dBHL between 2.0–4.0 kHz. Hearing thresh-
old measured in the 6th month showed a slight progression in the range above 1 kHz, but improved by the 12th 
month, to the results achieved at the 4th week. The effects of cochlear implantation on residual hearing have been 
studied in numerous studies, in which several key surgical and technical factors have been identified. Nucleus CI532 
is a Slim Modiolar electrode profile that is close to the modiolus, so it is expected to have a lower endocochlear hy-
drodynamic load since it lies in the covering of the osseus spiral lamina, thus less influencing the dynamics of the 
basilar membrane. However, the perimodiolar location of the electrode array allows the adjacent nerve elements of 
the spiral ganglion to be stimulated with a lower electrical intensity and a reduced surface that may be neuroprotec-
tive. Preservation of acoustic residual hearing following cochlear implantation improves the patient’s speech percep-
tion and the sound localization skills, particularly in difficult circumstances. Long-term residual hearing preservation 
may also be of great importance in the subsequent feasibility for regenerative procedures and drug treatments.
Keywords: cochlear implant, CI532 Slim Modiolar electrode, residual hearing preservation, soft surgery
Nagy R, Jarabin JA, Dimák B, Perényi Á, Tóth F, Szűts V, Jóri J, Kiss JG, Rovó L. [Possibilities for residual hearing 
preservation with Nucleus CI532 Slim Modiolar electrode array. Case report]. Orv Hetil. 2018; 159(41): 1680–
1688. 
(Beérkezett: 2018. március 1.; elfogadva: 2018. április 5.)
Rövidítések
ASSR = (auditory steady-state response) auditoros steady-state 
válasz; CI = cochlearis implantátum; CT = (computed tomog-
raphy) számítógépes tomográfia; BERA = (brainstem evoked 
response audiometry) agytörzsi kiváltott potenciál vizsgálat; 
DPOAE = (distortion product otoacoustic emission) disztorzi-
ós otoakusztikus emisszió; EAS = (electric-acoustic stimulati-
on) elektroakusztikus stimuláció
A legutóbbi években csaknem az összes súlyossági fokú 
és típusú halláscsökkenés rehabilitálhatóvá vált valamely 
implantálható hallásjavító rendszer alkalmazásával [1–3]. 
A cochlearis implantátumok (CI) évtizedek óta jó funk-
cionális eredménnyel biztosítják a különböző hátterű 
coch learis károsodásból eredő, súlyos fokú halláscsökke-
nések rehabilitációját mind gyermekek, mind felnőttek 
esetében [4]. A CI egy műtéti úton, részben beültetett 
hallásjavító eszköz, mely közvetlenül a csiga lumenébe 
vezetett, szőrsejtprotézisként működő elektródasoron át 
hozza ingerületbe a hallóideg még működő perifériás 
sejtjeit. A cochlearis implantátumok működési elve a kö-
vetkező: a külső beszédprocesszor a környezet hangjait 
elektromos jelekké alakítja át, melyeket az adótekercs az 
intakt bőr alatt elhelyezkedő belső implantátumegység-
hez továbbít. Az elektromos impulzusok ezt követően a 
belső elektronikához csatlakozó elektródasoron keresz-
tül közvetlenül a ganglion spirale sejtekhez, majd a cent-
1. ábra A cochlearis implantátum sematikus felépítése és működése. 
A külső beszédprocesszor (A) a környezet hangjait elektromos 
jelekké alakítja át, melyeket az adótekercs (B) az intakt bőr alatt 
elhelyezkedő belső implantátumegységhez (C) továbbít. Az 
elektromos impulzusok ezt követően a belső elektronikához 
csatlakozó elektródasoron (D) keresztül közvetlenül a ganglion 
spirale sejtekhez (E), majd a centrális hallópályán keresztül a 
hallókéreghez jutnak
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rális hallópályán keresztül a hallókéreghez jutnak (1/A–
E ábra). 
Megjelenésük óta a CI-k jelentős technikai fejlődésen 
mentek keresztül, ami időről időre a műtéti technikák 
adaptációját tette szükségessé. A kezdetektől fogva jelen 
volt az a törekvés, hogy a beteg esetleges residualis hallá-
sát a műtétet követően is megőrizzük [5]. Ezen koncep-
ció különösen előtérbe került minden olyan esetben, 
amikor a beteg mélyhang-hallása még hagyományos 
 hallókészülékkel is rehabilitálható volt, ugyanakkor a 
beszéd értés az egyidejűleg jelen lévő, súlyos fokú, kö-
zép- és magashang-vesztés miatt akusztikai erősítés mel-
lett is csaknem lehetetlen volt. Ez vezetett az elektroa-
kusztikus stimuláció (EAS) elvén működő implantátum-
rendszerek megjelenéséhez, melyek egyszerre alkal-
maznak hagyományos, akusztikai erősítést, továbbá 
implantált, elektromos stimulációt [6]. Az előbbi a mély 
hangok tartományában nyújt erősítést, míg az utóbbi a 
magasabb hangok területén biztosít kellő stimulációt, 
így optimalizálva a beteg beszédértését.
A residualis hallás posztoperatív megőrzése ösztönöz-
te az egyre vékonyabb, atraumatikus elektródasorok 
megalkotását is [5, 7]. A hallási teljesítmény maximalizá-
lása ugyanis a beillesztési trauma minimalizálásától függ 
[8]. Cochlearis implantáció során károsodhatnak az en-
docochlearis struktúrák, melyek azonnali vagy akár késői 
posztoperatív residualishallás-romlás forrásai lehetnek 
[9–11]. Az elektródasor bevezetése során esetlegesen ki-
alakuló belsőfül-trauma az eredete alapján, sebészi szem-
pontból, két csoportba sorolható. Ezek közül az első az 
elektródasornak a scala tympaniba történő célzott beve-
zetése [12]. A legelterjedtebb sebészi technikák ezt vagy 
a kerekablak-membránon át (úgynevezett „round win-
dow approach”), vagy egy úgynevezett cochleostomán, 
azaz a cochlea basalis kanyarulatának mesterséges furatán 
át valósítják meg [10] (2. ábra). A második jelentősebb 
csoportot az elektródasor minimális traumát okozó be-
vezetése képezi. Ebben szintén számos tényezőnek lehet 
meghatározó szerepe, mint például: (1) az elektróda be-
vezetése során keletkező közvetlen trauma; (2) az im-
plantáció kapcsán a perilympha folyadéktérben kialakuló 
nyomáshullám hatása; (3) a fúró által okozott vibráció, 
hangártalom, esetleg hőtrauma; (4) perilymphavesztés; 
(5) a belső fül folyadéktereinek homeosztázisában létre-
jövő változások; endolymphaticus hydrops kialakulása; 
(6) a csiga lumenének késői fibroticus, csontos átalakulá-
sa [13, 14]. Az elektródasor hossza és keresztmetszete 
szintén korlátozhatja a posztoperatívan elérhető residua-
lis hallás megőrzését [15]. A közép- és a belső fül átfogó 
preoperatív radiológiai elemzése segíthet mind a műtéti 
behatolás megtervezésében, mind az elektródaprofil ki-
választásában [16–18].
2. ábra A Cochlear® Nucleus CI532 Slim Modiolar elektródaprofil endocochlearis elhelyezkedése. A cochlea megnyitásának leggyakoribb sebészi kapui
(A) A sémás ábra a labyrinthus szerkezetét ábrázolja, melyen jól látható a fenestra rotundán (fekete nyíl) át bevezetett elektródasor (narancsszínű). 
Alternatív sebészi behatolásként, a cochleostoma furatának helyét az ábrán fekete csillag jelöli. Az ábra jobb oldalán kinagyított átmetszeti kép a csiga 
mikroszkópos vázlati szerkezetét, az implantáció sikeressége szempontjából nélkülözhetetlen folyadéktereit ábrázolja (ST – scala tympani; SV – scala 
vestibuli; DC – ductus cochlearis)
(B) Látható a scala tympaniba vezetett elektródasor intracochlearis elhelyezkedése két, eltérő elektródaprofil fizikai paramétereinek illusztrációjával. 
A CI532-es (narancsszínű, tömör átmetszetű) elektródaprofil körülbelül 60%-os relatív keresztmetszet-csökkenése, következményes intracochlearis-
pozíció-változása szembetűnő a korábbi, CI512-es (narancsszínű, szaggatott körvonalú) elektródaprofilhoz képest
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EAS-t alkalmazva a magashang-tartományban károso-
dott szőrsejtek területét, azaz a basalis régiót sok esetben 
egy rövid elektródasor bevezetésével fedik le, mellyel 
megkímélhető az apicalis cochlearis régiók szerkezete, 
működése. Ez esetben a kihívást a residualis hallás hosz-
szabb távú megőrzése jelenti [19]. Ha ugyanis a mély-
hang-hallásban progresszió következik be, az eredetileg 
optimális hosszúságú elektróda, fizikai lefedettség hiá-
nyában, már nem lesz képes pótolni a cochlea ezen régi-
ójának funkcióját. A progresszió hátterében kiváltó ok-
ként szerepelhet késői endocochlearis fibrosis vagy 
csontszövetképződés is [20]. Az ebben a helyzetben fel-
merülő teljes belsőegység-csere, hosszabb elektródasor 
bevezetése ennek kapcsán akár fizikai akadályba is ütköz-
het. Elzáródás hiányában ugyanakkor akár több egymást 
követő implantáció szükségessé válhat, követve a beteg 
hallásának folyamatos rosszabbodását, ezzel nyilvánvaló 
sebészi, altatási terhet róva a betegre. Mindemellett szá-
mos finanszírozási kérdés is felmerülhet. 
A cél tehát egy atraumatikus elektródasor kifejlesztése 
volt, mely a residualis hallás maximális megőrzése mellett 
képes az elektromos hallás hosszú távú biztosítására. 
A  cochlea teljes hosszában bevezetve az elektródasort 
kezdetben az EAS részeként üzemelhet, majd egy esetle-
gesen bekövetkező mélyhanghallás-vesztés esetén, az 
apicalisan elhelyezkedő elektródákat aktiválva, csupán az 
implantátum programozásának módosításával biztosít-
ható újra a teljes cochlea elektromos hallás lefedése. 
A folyamat lényege tehát egy hibrid, akusztikus és elekt-
romos rendszerről tisztán elektromos rendszerre történő 
áttérés a beültetett elektródasor cseréje nélkül.
Az előbbi feltételeknek véleményünk szerint megfele-
lő elektródasor (Cochlear® Nucleus „CI532 Slim Modi-
olar”) 2015 novemberében „closed-market release” ke-
retében a Szegedi Tudományegyetem Fül-Orr-Gégészeti 
és Fej-Nyaksebészeti Klinikáján került beültetésre első-
ként a világon (operatőr: Prof. Dr. Rovó László tanszék-
vezető egyetemi tanár).
Klinikánkon ez idáig 89 esetben (69 beteg) ültettünk 
be CI532-es elektródasort, melyek közül 40 fő esetében 
mértünk preoperatív residualis hallást. A homogén be-
tegcsoportok adatainak részletes feldolgozása jelenleg 
folyamatban van.
Jelen tanulmányunkban egy olyan esetről számolunk 
be, amelyben Cochlear® Nucleus CI532 Slim Modiolar 
elektródát ültettünk be residualis hallással rendelkező 
betegnek. Vizsgálatainkkal arra kerestük a választ, hogy 
rövid vagy akár hosszú távon is megőrizhető marad-e az 
akusztikai hallás. 
Anyag és módszer
Nucleus CI532 Slim Modiolar elektródaprofil
Az elektródaprofilokat a modiolustól való távolságuk 
alapján perimodiolaris, „mid-scala”, illetve „lateral-wall” 
kategóriákba sorolhatjuk (3. ábra) [21]. A Nucleus 
CI532-es elektródasor jelenleg a világ egyik legkisebb 
átmérőjű perimodiolaris pozíciójú elektródaprofilja. Ba-
salisan 0,5 mm, míg apicalisan 0,3 mm átmérőjű, ezzel 
mintegy 60%-ban kisebb térfogatú, mint a gyártó szin-
tén perimodiolaris elhelyezkedésű, előző generációs 
elektródaprofilja, az úgynevezett Nucleus Contour Ad-
vance (4. ábra) [22]. Különleges, rugalmas háromdi-
menziós (3D-s) konformációjának köszönhetően lehe-
3. ábra Az elektródaprofilok csoportosítása a modiolustól való távolsá-
guk alapján. Az elektródaprofilok modiolustól való távolságuk 
alapján (A) perimodiolaris, (B) mid-scala, (C) „lateral-wall” tí-
pusba sorolhatók. A jelen cikk tárgyát képező Nucleus CI532-es 
elektróda a perimodiolaris csoport tagja
4. ábra Perimodiolaris elektródasorok összehasonlítása. Az ábrán a Nucleus CI532 vékony, perimodiolaris elektródaprofil méretei láthatók az előző, úgyne-
vezett Contour Advance elektródaprofilhoz képest. A Nucleus CI532-es elektródasor jelenleg a világ legkisebb átmérőjű perimodiolaris pozíciójú 
elektródaprofilja. Basalisan 0,5 mm, míg apicalisan 0,3 mm átmérőjű, ezzel mintegy 60%-ban kisebb térfogatú, mint a szintén perimodiolaris elhelyez-
kedésű, előző generációs elektródaprofil, az úgynevezett Nucleus Contour Advance CI512
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tővé teszi, hogy az elektródák a lamina spiralis ossea 
eredése alatt helyezkedjenek el, így biztosítva, hogy a 
stimulációs pontok a ganglion spirale sejtjeinek közelébe 
kerüljenek (2/B ábra). Atraumatikus kialakítása biztosít-
ja az endocochlearis finomstruktúrák megőrzését [23]. 
Egyedülálló beillesztési mechanizmussal rendelkezik, 
amely a sebész számára lehetővé teszi, hogy kiválaszthas-
sa a legmegfelelőbb megközelítést a cochlea anatómiájá-
nak függvényében. A biztonság érdekében az elektróda 
újratölthető vezetőeszközzel rendelkezik, mely szignifi-
káns mértékben növeli az elektróda optimális helyzetbe 
kerülésének esélyét [21].
Minimálisan invazív sebészi technika
A residualis hallás cochlearis implantáció során történő 
megőrzésének szándéka vezetett az úgynevezett „soft 
surgery”, azaz minimálisan invazív műtéti eljárások meg-
jelenéséhez. Ezek alapvetően meghatározzák a cochlea 
megnyitásának és az endocochlearis manipulációknak 
minden olyan elemét, amely makro- és mikroszerkezeti 
károsodások által negatívan befolyásolhatja a posztope-
ratívan elérhető hallásteljesítményt (direkt trauma és/
vagy különböző anyagok bekerülése a cochleába stb.). 
A minimálisan invazív cochlearis implantációs eljárás te-
hát nem konkrét műtéti típus, hanem inkább olyan sza-
bályok összessége, melyeket követve egyre tökéletesebb 
funkciómegőrzés lehetséges. A fogalmat és a főbb szem-
pontokat elsőként Lehnhardt közölte 1993-ban [24], 
ami számos később megjelent publikáció alapját jelentet-
te [25]. A residualis hallás megőrzésének szándéka leg-
újabban az EAS-rendszerekkel történő hallásrehabilitá-
ció során merül fel [26–28].
Minimálinvazív technikát alkalmazva egyaránt választ-
hatunk kerek ablakon, kiterjesztett kerekablak-behatolá-
son vagy cochleostomán át történő elektródabevezetést 
[11]. A csont szükséges mértékű elfúrásához minden 
esetben 1 mm átmérőjű gyémántfúrót használunk lassú 
fordulatszámon, ezzel elkerülve a fúrás során keletkező 
hang- és hőártalmat [13, 14]. Az endosteum megnyitása 
előtt, annak felszínére szteroidtartalmú oldatot vagy nát-
rium-hialuronát-tartalmú készítményt helyezhetünk. Az 
endosteum megnyitásához mikrotűt vagy -horgot, to-
vábbá különböző lézereket használhatunk. A belső fül 
megnyitását követően fokozottan ügyelnünk kell arra, 
hogy elszívás közben nehogy perilymphavesztést okoz-
zunk. A scala tympani csupán a lehető legrövidebb ideig 
lehet nyitva, ugyanis azon mint behatolási kapun át pri-
meren vagy az elektródához tapadva szekunder módon 
csontpor, vér vagy egyéb anyag juthat a belső fülbe, mely 
számos direkt és/vagy másodlagos károsodás forrása le-
het, s ez végső soron a posztoperatív residualis hallás 
csökkenéséhez, elvesztéséhez vezethet. Bevezetése előtt, 
a Nucleus CI532-es elektródaszálat az implantátumhoz 
tervezett speciális vezetősínbe vissza kell húzni. Ez előse-
gíti az optimális implantációs szög meghatározását, 
megtartását. Az elektródaszál bevezetése a lehető legki-
sebb erő kifejtése mellett kell, hogy történjen. Minden 
érzékelhető ellenállás a basilaris membrán, a lateralis sca-
la tympani fal vagy a stria vascularis kontaktusát, követ-
kezményes sérülését jelezheti. Az elektródaszál beveze-
tését elősegítheti felszínének szteroidos oldattal vagy 
nátrium-hialuronáttal történő bevonása. Amint az elekt-
róda a megfelelő hosszúságban bevezetésre került – amit 
markergyűrűk jeleznek –, a kerek ablakot vagy a cochleo-
stomát autológ szövettel (például fascia, izomszövet) le-
zárjuk, megelőzve a további perilymphavesztést [25].
Az implantátumtestet és a referenciaelektródát a gyár-
tó által kiadott templát segítségével a bőr alatt kialakított 
zsebbe helyezzük.
Betegadatok
Nőbetegünk 1987-ben született. Veleszületett hallás-
csökkenése miatt gyermekkora óta hagyományos, lég-
vezetéses hallásjavító készüléket viselt mindkét fülén. 
A cochlearis implantációt 6 hónappal megelőzően hallás-
csökkenésében mindkét oldalon kifejezett progressziót 
mértünk, így már készülékeinek viselése mellett sem volt 
kielégítő beszédmegértési képessége. Műtéti alkalmassá-
gát részletes audiológiai és radiológiai tesztekkel bíráltuk 
el. Ezt követően az implantációt a beteg 30. életévében 
végeztük el általános anesztéziában. Mivel a beteg a mű-
tétet megelőzően mindkét fülén rendelkezett residualis 
hallással, vékony perimodiolaris elektródaprofil (CI532 
Slim Modiolar implantátum) alkalmazása mellett dön-
töttünk. A műtétet a beteg jobb fülén végeztük el a fen-
tebb részletezett minimálisan invazív sebészi technikát 
alkalmazva kerek ablakon keresztül.
Eredmények
Preoperatív hallásvizsgálatok
A preoperatív hallásdiagnosztika teljes körű szubjektív és 
objektív tesztekből állt. Az elvégzett tisztahang-küszöb-
audiometria a beszédfrekvenciákon (0,25–1,0 kHz) átla-
gosan 85 dBHL hallásküszöböt igazolt (5/A ábra), míg 
a beszédaudiometria az audiométer méréshatáráig nem 
volt vizsgálható.
Az objektív teszteket normális középfül-ventiláció 
mellett végeztük (normál A típusú timpanogram mind-
két oldalon). A disztorziós otoakusztikus emisszió 
(DPOAE) mérésével egyik oldalon sem volt regisztrálha-
tó külsőszőrsejt-aktivitás, ami sensorineuralis halláscsök-
kenés esetében belsőfül-eredetet igazol. Agytörzsi kivál-
tott potenciál vizsgálattal (BERA) nagy intenzitás mellett 
még éppen regisztrálható, kis amplitúdójú, ugyanakkor 
normál atenciájú, reprodukálható válaszokat regisztrál-
tunk, ami szintén a Corti-szerv-eredet mellett szól. Az 
agytörzsi szakaszon neuralis érintettségre (úgynevezett 
retrocochlearis laesióra) utaló jeleket nem láttunk. Audi-
toros steady-state válaszok (ASSRs) vizsgálata során az 
1685ORVOSI HETILAP  2018  ■  159. évfolyam, 41. szám
ESETISMERTETÉS
objektív hallásküszöböt mindkét oldalon nagy-súlyos fo-
kúnak becsültük (6. ábra).
Eredményeink alapján tehát a beteg bizonyos mértékű 
residualis hallással rendelkezett ugyan, ez azonban a ha-
gyományos légvezetéses erősítéssel nem lett volna kellő 
mértékben rehabilitálható. Az objektív tesztek a nervus 
cochlearis retrolabyrinther károsodását nem vetették fel, 
melyet a preoperatívan elvégzett nagy felbontású pira-
miscsont-CT-vizsgálat szintén kizárt. Belsőfül-fejlődési 
rendellenesség nem ábrázolódott.
Mivel a beteg a cochlearis implantáció audiológiai és 
radiológiai indikációs kritériumainak megfelelt, műtétet 
javasoltunk.
Posztoperatív hallásvizsgálatok
Az első ellenőrző tisztahang-küszöbaudiometriai vizsgá-
latunkra a negyedik posztoperatív héten került sor (5/B 
ábra). A beszédfrekvencia-tartományt tekintve 0,25–1,0 
kHz között 5–10 dBHL, míg 2,0–4,0 kHz-en 20–25 
dBHL mértékű iniciális hallásküszöbromlást tapasztal-
tunk. Ezt követően a posztoperatív hatodik és tizenket-
tedik hónapban újabb kontroll-hallásvizsgálatot végez-
tünk. A 6. hónapban mért hallásküszöb 1 kHz felett 
ismét progressziót mutatott (5/C ábra), ugyanakkor a 
posztoperatív 12. hónapban (5/D ábra), javulást köve-
tően, a 4. héten kapott eredményekkel megegyező hal-
lásküszöbértékeket mértünk. A posztoperatív teszteket 
tisztán akusztikus ingerrel, a cochlearis implantátum ki-
kapcsolása mellett végeztük el.
Elektrofiziológia
A Nucleus CI532 egy 22 csatornából álló vékony, peri-
modiolaris elhelyezkedésű elektródaprofillal rendelkező 
implantátum. A posztoperatív hallásvizsgálatokkal egy 
időben elvégzett elektródánkénti impedanciamérések 
számos ingadozást mutatva, a 10–22. elektródatarto-
mányban már a 6. hónapban, míg az 1–9. elektródákon 
a 12. hónapban válnak relatíve stabillá, kiegyenlítetté 
(7. ábra), ami az elektródasor megfelelő integrációjára, a 
belsőfül-homeosztáziásnak a rendezettségére utalhat.
Megbeszélés
Az akusztikai residualis hallás cochlearis implantáció kap-
csán történő megőrzése javítja a posztoperatívan elérhe-
tő periodicitást és spektrális felbontást, aminek köszön-
hetően javul a beteg beszédértése és hanglokalizációs 
képessége, különösen nehezített körülmények között, 
ezért kiemelkedő annak megőrzése [29–35]. 
A cochlearis implantáció residualis hallásra gyakorolt 
azonnali hatásait több tanulmány is vizsgálta, melyekben 
számos sebészi és technikai tényező kulcsszerepét meg-
határozták [10, 36, 37]. Hasonló vizsgálatok kutatják a 
mikrofülsebészeti beavatkozások labyrinthfunkciókra 
gyakorolt hatásait [38]. Az implantációt követő időszak-
ban ugyanakkor számolnunk kell késői komplikációkkal 
is, úgymint endocochlearis kötő- vagy csontszövetkép-
ződéssel, mely másodlagosan a residualis akusztikai hal-
lás romlásához, elvesztéséhez vezethet [20]. Erre a leg-
nagyobb valószínűség a kiterjesztett kerekablak-feltárás-
kor („extended round window approach”) mutatkozik, 
melynek során az endosteum károsodása vált ki új szöve-
ti proliferációt. A legcsekélyebb a károsodás kialakulásá-
nak valószínűsége minimálinvazív kerekablak-behatolás 
során [10]. A cochlea hidrodinamikai rendszerének ká-
rosodása ugyanakkor létrejöhet egy, az alaphártya moz-
gását korlátozó elektródasor jelenléte miatt is. Ekkor a 
membrana basilaris eltérő maximummal és helyen tér ki 
a különböző hangokra, így a haladóhullám terjedését be-
folyásoló elektródasor a mély frekvenciákért felelős api-
calis régió elemeit is károsíthatja, úgynevezett cochlearis 
vezetéses halláscsökkenést okozva [39, 40]. Az új típusú, 
vékony átmérőjű, modiolushoz közeli elhelyezkedésű 
elektródasorok várhatóan kisebb hidrodinamikai terhe-
lést jelentenek, hiszen a lamina spiralis ossea takarásában, 
az alatt helyezkednek el, a membrana basilarist nem érin-
tik (2. ábra). Az elektródasor perimodiolaris elhelyezke-
5. ábra Pre- és posztoperatív tisztahang-küszöbaudiometriai eredmé-
nyek. Az implantációt a jobb fülön végeztük el (piros görbék); 
az ellenoldali hallást a kék görbék jelzik. A preoperatív tiszta-
hang-küszöbaudiometria a beszédfrekvenciákon (0,25–1,0 
kHz) átlagosan 85 dBHL hallásküszöböt igazolt (A). A negye-
dik posztoperatív héten a beszédfrekvencia-tartományt tekintve 
0,25–1,0 kHz között 5–10 dBHL, míg 2,0–4,0 kHz-en 20–25 
dBHL mértékű iniciális hallásküszöbromlást tapasztaltunk (B). 
A 6. hónapban mért hallásküszöb 1 kHz felett ismét progresszi-
ót mutatott (C), ugyanakkor a posztoperatív 12. hónapban, ja-
vulást követően, a 4. héten kapott eredményekkel megegyező 
hallásküszöbértékeket mértünk (D). A 6. hónapban elvégzett 
szabad hangteres hallásküszöb-vizsgálat a jobb fülön viselt coch-
learis implantátummal közel a szociális hallásküszöbnek megfe-
lelő hallást igazolt, átlag 35–40 dBHL küszöbszinttel. A poszt-
operatív 12. hónapban mért szabad hangteres hallásküszöb 
további javulást mutatott, átlag 25–30 dBHL-nek bizonyult
Jelölések: –X– = bal oldali légvezetéses hallásküszöb; –O– = 
jobb oldali légvezetéses hallásküszöb; –Δ– = CI-vel mért hallás-
küszöb szabad hangtérben
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dése mindemellett lehetővé teszi, hogy a ganglion spirale 
szomszédos idegelemeit alacsonyabb áramintenzitással, 
kisebb felületen ingerelhessük.
Korai post mortem kadáverkísérletek során igazolták, 
hogy az interscalaris (azaz a scala tympaniból a scala ves-
tibuliba történő) elektródadiszlokációhoz már 42–122 
mN (átlagosan 88 mN) erő kifejtése is elegendő, mely-
nek manuális érzékelhetősége kérdéses [41]. Nagy eset-
számon (n = 100) végzett vizsgálatokkal kimutatták, 
hogy cochleostoma készítése során szignifikáns mérték-
ben nőtt a valószínűsége, hogy az elektródasor a scala 
vestibuliban helyezkedjen el, ami a betegek beszédértés-
javulásának elmaradásában is megnyilvánult [42]. 
Számos tanulmányban az intraoperatívan elvégzett 
electrocochleographiai mérések segítségével követhető-
nek tartják az elektróda bevezetése során létrejövő trau-
mát, végső soron a posztoperatív residualis hallás megőr-
zésének tényét [12, 43, 44].
A posztoperatív időszakban esetünkben is mérhető 
volt a residualis hallás küszöbértékeinek fluktuációja. 
A funkcionális romlás hátterében az elektródasor megfe-
lelő integrációja, a belsőfül-homeosztázisnak a rendező-
dése, végső soron egy adaptációs folyamat állhat. Az 
implantáció által facilitált neuroregeneráció ugyanakkor 
a hallásküszöb javulását eredményezheti.
Az EAS megvalósításához a külső hibrid beszédpro-
cesszorok (akusztikus és elektromos) önmagukban nem 
elegendőek, az elektródasornak is atraumatikus profillal 
kell rendelkeznie, hogy a belső fül struktúráinak megőr-
zése révén lehetőség legyen a residualis akusztikai hallás 
hosszabb távú megőrzésére [45].
Esetünk jól demonstrálja, hogy minimálisan invazív 
technikát, valamint atraumatikus elektródasort alkalmaz-
va a residualis hallás hosszabb távon megőrizhető. Az új 
típusú CI532 Slim Modiolar elektródasorral nyert ked-
vező tapasztalataink előrevetítik annak lehetőségét, hogy 
a cochlea minden régiójának szerkezeti és funkcionális 
6. ábra Preoperatív objektív hallásküszöbértékek jobb és bal oldalon. Auditoros steady-state válaszok (ASSRs) vizsgálata során az objektív hallásküszöböt, 
ezzel a residualis hallást mindkét oldalon nagy-súlyos fokban emelkedettnek mértük. A hallásküszöb a jobb oldalon (A) az objektív hallásküszöb 80–90 
dB corHL, míg a bal oldalon (B) 90–100 dB corHL mértékűnek bizonyult, bal oldalon 500 Hz-en relatíve megkímélt residualis hallással (corHL: 
hangintenzitás-korrekciós faktor figyelembevételével, mely tükrözi a beteg életkorát és a rögzítés körülményeit)
7. ábra Posztoperatív elektródaimpedancia-változások. A posztoperatív 
hallásvizsgálatokkal egy időben elvégzett elektródánkénti impe-
danciamérések számos ingadozást mutatva, a 10–22. elektróda-
tartományban már a 6. hónapban, míg az 1–9. elektródákon a 
12. hónapban válnak relatíve stabillá, kiegyenlítetté. Ez az elekt-
ródasor megfelelő integrációjára, a belsőfül-homeosztázisnak a 
rendezettségére utalhat. A diagram felső tengelyén a különböző 
elektródák frekvencialefedettség-átlaga került feltüntetésre
Jelölések: –●– = posztoperatív 4. hét; –▲– = posztoperatív 6. 
hónap; –■– = posztoperatív 12. hónap
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épsége megőrizhető, ugyanakkor végleges megoldást 
nyújthat egy esetlegesen bekövetkező késői halláscsökke-
nés-progresszió kapcsán, amikor is elegendő csupán az 
implantátum pszichofizikai módszerekkel történő át-
programozása.
Eredményeink alapján, amennyiben a kezdeti tapasz-
talatoknak megfelelő biztonsággal és hatékonysággal 
őrizhető meg az akusztikai residualis hallás, úgy lényege-
sen kevesebb műtéti és altatási teher mellett leszünk ké-
pesek tartósan kiemelkedő hallásrehabilitációt biztosítani 
az EAS indikációjában is, ami jelentős életminőség-javu-
lást, továbbá financiális tehercsökkenést eredményez a 
beteg és a társadalom számára egyaránt.
Emellett a residualis hallás hosszabb távú megőrzése 
kiemelkedő fontosságúnak bizonyulhat a későbbi rege-
neratív eljárások, gyógyszeres kezelések megvalósítható-
sága kapcsán is [46, 47].
Következtetés
A cochlearis implantáció során alapvető szerep jut, a mi-
nimálinvazív technikák mellett, az individuális igényeket 
figyelembe vevő, hosszú távon is biztonságos hallásmeg-
őrzést nyújtó elektródasorok alkalmazásának. Esetünk 
jól demonstrálja a Nucleus CI532 Slim Modiolar elekt-
ródaprofil hatékonyságát residualis akusztikai hallás ese-
tében, ami előrevetíti az elektródasorok ezen generáció-
jának EAS-rendszerek részeként történő alkalmazhatósá-
gát, hosszabb távon biztosítva egy esetlegesen a jövőben 
megjelenő, sejtregeneráción alapuló új terápiás módszer 
alkalmazhatóságának alapját.
Anyagi támogatás: A közlemény megírása anyagi támo-
gatásban nem részesült.
Szerzői munkamegosztás: N. R.: Elektrofiziológiai méré-
sek elvégzése, az ábrák megszerkesztése, a kézirat nyers 
változatának elkészítése. J. J. A.: Audiológiai leletek érté-
kelése, a kézirat végleges szövegének megírása. D. B.: 
Elektrofiziológiai és audiológiai mérések elvégzése. 
P. Á.: A cochlearis impantációs kivizsgálás megszervezé-
se, részvétel a műtét folyamatában. T. F.: Az elektrofizi-
ológiai mérések értékelése, lektorálás. Sz. V.: A belső fül 
regenerációját vizsgáló kutatások értékelése, kéziratra 
adaptálása. J. J.: A kézirat lektorálása, publikációra való 
felkészítése. K. J. G.: Az elektrofiziológiai mérések, audi-
ológiai vizsgálatok menetének beállítása, ellenőrzése, 
eredményeik értékelése, tudományos tanácsadás. R. L.: 
Az implantációs team vezetője, a cochlearis implantáció 
elvégzése, a beteg posztoperatív gondozása, a végleges 
kézirat lektorálása, a publikáció folyamatának nyomon 
követése, irányítása, lektorálás. 
Érdekeltségek: A szerzőknek nincsenek érdekeltségeik.
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Introduction
There are currently different trends in cochlear implant
electrode design [1]. The manufacturers provide a var-
iety of implant configurations including different re-
ceiver-stimulators, electrode arrays (e.g. straight or pre-
curved, full-length or short) and sound processors to
choose from, which can facilitate decision making on an
individual basis. Proximity to the modiolus [2, 3], elec-
trical current requirements [4], energy consumption,
trauma to the cochlea [5], combined electro-acoustic
stimulation [6, 7]), preservation of cochlear structures
with low-trauma surgical technique [3, 8–10] and hear-
ing preservation [11–14] are important aspects of im-
plant design which have become the focus of many
discussions and studies.
For example, recent evidence suggests that speech dis-
crimination is not improved by deep insertion, but it is
significantly improved by perimodiolar position of the
electrode [15].
Studies in implanted recipient groups using multiple
implant types make it difficult to compare the influence
of the implant electrode characteristics on outcomes in
the presence of additional variables such as implant elec-
tronics, sound processors and speech coding paradigms.
Hence, to reduce the number of variables, comparison
of the influence of electrode designs on outcomes could
be interpreted more effectively if a consistent receiver-
stimulator design and a common sound processor are
used. Recent publications [16–20] represent imaging and
electrophysiological results with CI532, but no compara-
tive studies have yet been published.
Our center’s postoperative radiological comparative
study demonstrated that the Slim Modilar electrode
array took a closer position to the modiolus than the
Contour Advance electrode array [21].
As a consequence, the authors’ aim in this multicenter
study that is to their knowledge the first with this focus
was to compare the influence of various electrode de-
signs upon selected electrophysiological outcomes for
cochlear implant recipients using the same model of re-
ceiver-stimulator, Cochlear™ Nucleus® Profile Series and
sound processor in a retrospective study.
Materials and methods
Inclusion and allocation of subjects
A total of 139 consecutive subjects who were implanted
between 13 June 2014 and 4 May 2017 with a Profile
CI532 (CI532), a Profile CI512 (CI512), and a Profile
CI522 (CI522) device manufactured by Cochlear Ltd.,
Australia and gave their informed consent were recruited
to this retrospective study from two tertiary referral im-
plant centers. Time periods of the study recruitment were
from 13 June 2014 to 14 December 2015 for CI512, from
13 November 2015 to 4 May 2017 for CI532and 11 March
2015 to 29 November 2016 for CI522. All subjects were
examined with high resolution computed tomography
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and/or magnetic resonance imaging before surgery. Exclu-
sion criteria were cochlear malformations, cochlear oto-
sclerosis, obliterative postmeningitis changes and
electrode tip foldover. To the authors knowledge there
were no neural disorders in either group. Postoperative
radiography was performed in each subject to confirm
that the active electrode occupied an intracochlear pos-
ition with no complications or abnormal electrode
position.
The subjects were allocated into groups based on the
electrode type implanted as shown in Table 1. Those
who received a CI532 formed group 532, those who re-
ceived a CI512 formed group 512, and those who re-
ceived a CI522 formed group 522. Subjects were
consecutively treated as part of routine clinical practice
that was comparable at each respective implant site.
 A total of 159 ears in 139 subjects were implanted
with devices, including the same implant receiver-
stimulator electronics. CI532 had a 22 electrode
array which was perimodiolar and with a relatively
smaller diameter (named Slim Modiolar), CI512 had
a 22 electrode array which was perimodiolar with a
relatively larger diameter (named Contour Advance),
and CI522 had a 22 electrode array which was
straight, also with a relatively small diameter (named
Slim Straight). A total of 54 ears were implanted
with CI532 (all in Clinic 1), 54 ears with CI512 (51
in Clinic 1 and 3 in Clinic 2), and 51 ears with
CI522 (47 in Clinic 2 and 4 in Clinic 1). Patients
who were implanted with CI532 formed the test
group. Two control groups were formed from
patients who were implanted with Implants 512 and
522. The underlying causes of hearing loss were
congenital, progressive, unknown and others (e.g.
choesteatoma, infection, Meniere’s disease,
meningitis, ototoxic drugs, sudden hearing loss,
trauma) in 29, 22, 16, and 33% for group 532, 28, 26,
28, and 17% for group 512, and 17, 23, 35, and 25%
for group 522, respectively.
Implantation technique
The electrode arrays were inserted into the cochlea ac-
cording to the manufacturer’s instructions provided in
the physician’s surgical guide. The method of electrode
insertion was identical in both implant clinics [22]. Full
insertion was achieved via the extended round window
approach with CI532 and CI512 and via the round win-
dow approach with CI522 in all ears. The AOS (advance
off-stylet) technique was used for CI512 and the free-
hand technique was used for CI522. Electrode choice
was dependent on the actual implant pool of each center
(regulated by the health authorities). The age of the pa-
tients did not influence implant choice. Discussion of
hearing preservation was not an objective of this study.
Electrophysiological testing
The three different types of electrode arrays were com-
pared with regards to outcomes from intraoperative and
3-months postoperative electrophysiological testing per-
formed as per routine clinical protocol (Table 2).
Intraoperative electrophysiological tests were carried
out as part of the regular fittings with Nucleus Custom
Sound 4.4 software: Impedance was measured for each
electrode, the electrical stapedial reflex threshold (ESRT)
with 25 μs pulse width for every second electrode con-
tact (No. 2, 4, 6 etc.) and neural response telemetry
threshold (T-NRT) for 6 (No. 2, 6, 10, 14, 18 and 22)
electrode contacts. ESRT values were compared in
Table 1 Subject demographics for each subject group. Note: For continuous variables, the mean and + 1 standard deviation are
shown in brackets
Subject group 532 512 522
Device CI532 CI512 CI522
Electrode type Slim modiolar Contour advance Slim straight
Number of patients 46 45 48
Number of ears 54 54 51
Age (year) 25.17±26.29 20.80±25.87 55.36±28.59
Sex (male/female) 25/29 23/31 33/18
Duration of deafness (year) 2.94±7,46 3.06±9.34 3.13±12.99
Cause of deafness
Congenital 29% 28% 17%
Progressive 22%, 26% 23%
Unknown 16% 28% 35%
Others 33% 17% 25%
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groups 532 and 512. T-NRT values in group 532 were
compared with those in both control groups. A common
sound processor (Nucleus CP910) was used.
The centers followed their normal routine protocol,
thus the electrophysiological measurement protocol of
the two centers was not identical, i.e. intraoperative
ESRT testing, postoperative T-NRT measurements were
not included in the routine protocol by Clinic 2, and
thus CI522 was not analyzed with regards to these pa-
rameters. Furthermore, postoperative NRT was not mea-
sured for subjects in each group, where the current
required to elicit a threshold response exceeded their
discomfort or pain level.
The first fitting was performed 4 weeks after surgery in
each case. In order to determine the electric threshold (T-
levels), and comfort threshold (C-levels), the subjective fit-
ting method was used in adults and the semi-objective
NRT based fitting (based on the intraoperative T-NRT
results) was applied in children [23, 24]. Default MAP
parameters (25 μs pulse width, 900 Hz stimulation rate
and 8 maxima) were used. Postoperative NRT was mea-
sured 2 months after the first fitting, i.e. 3-months follow-
up. C-levels at first fitting and 3-months follow-up fitting
and T-NRT at 3-months follow-up were compared.
Outcomes for precurved slim perimodiolar electrode
design, used at one implant clinic were compared to out-
comes for two control groups of recipients implanted
with precurved perimodiolar and straight electrodes in
both implant clinics. Electrode designs were compared
on the basis of outcomes for intraoperative objective
electrophysiological measures and postoperative thresh-
old levels and comfort levels to characterize electrode
position within the cochlea.
Statistical analysis
Statistical analysis with the Student’s t-test (P < 0.05) and
one-way repeated measures ANOVA test were per-
formed with 95% confidence interval (p < 0.05). Before
the calculation, tests for normality of data distribution
were performed. Bonferroni correction was used as
needed to consider multiple variables (e.g. comparison
of all three implant groups). The comparison was made
on each electrode and all of the electrodes (Grand
average). The tests were performed with Microsoft Excel
2016 and SPSS for Windows.
Results
All subjects received Nucleus Profile implants. The only
difference was the type of electrode. The patient groups
were similar in subject numbers, etiology and duration
of deafness, and indications.
Electrophysiology testing
Intraoperative measurements
Firstly, intraoperative electrical stapedial reflex threshold
(ESRT, Fig. 1) and Neural Response Telemetry (T-NRT,
Fig. 2), results were compared across implant groups. A
stapedial reflex was tested in all subjects in group 532
and 512 and could be elicited in 44 out of 54 cases in
group 532 and in 47 out of 54 cases in the control group
(group 512). Figure 3 shows that the mean ESRTs were
lower in group 532 than in group 512. This difference
Table 2 Summary of the intraoperative and postoperative evaluation protocols and available data sets for each type of electrode.
The routine protocol in Clinic 2 did not include measurement of intraoperative ESRT, and postoperative T-NRT
Group 532
Nucleus CI532 (n/54 implants)
Group 512
Nucleus CI512 (n/54 implants)
Group 522
Nucleus CI522 (n/51 implants)
intraoperative ESRT 44 47 0
intraoperative T-NRT 50 47 43
postoperative C-level (1 month) 54 54 51
postoperative C-level (3 month) 54 54 51
postoperative T-NRT (3 month) 32 36 0
Fig. 1 Intraoperative T-NRT values in all groups: Groups 532 (n = 50),
512 (n=47) and 522 (n=43). The “+” stands for significant difference
between groups 532 and 512. The “*” represents a significant difference
between groups 532 and 522. Error bars represent the standard deviation
(SD). The mean NRTs proved to be lower in each electrode in group 532
when compared with both control groups. The difference was significant
in 5 measured electrodes when compared with 522 and 3 measured
electrodes when compared with 532 (t-probe: p<0.05). Grand T532–512
means statistical comparison between groups 532 and 512. Grand T532–522
means statistical comparison between groups 532 and 522
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was significant (t probe: p = 0.007) for electrode contact
2. Grand average (all electrodes) statistic calculation
(Grand T532–512) showed significant differences between
groups 532 and 512 (p < 0.05).
Intraoperative NRT measurements were performed in
all three groups. The neural response threshold was
tested in all subjects and could be elicited in 50 out of
54 (group 532), 47 out of 54 (group 512), and 43 out of
51 (group 522) cases. Repeated ANOVA analysis re-
vealed significant difference p < 0.05) between the three
groups. On examining the significance in pairs, we found
that the mean T-NRTs (Fig. 2) proved to be lower in
each electrode in group 532 when compared with each
control group. The difference was significant in 5 mea-
sured electrode contacts when compared with CI522
and 3 measured electrode contacts when compared with
CI512 (t-probe: p < 0.05). Grand average (all electrodes)
statistic calculation (Grand T532–512 and Grand T532–522)
showed significant lower T-NRT values in group 532
compared with the two control groups (p < 0.05).
Postoperative C-levels
The subjects were scheduled for the first fitting 4 weeks
after surgery. C-levels during the first fitting were com-
pared in patient groups with different implants (Fig. 4).
No significant difference in mean C-levels was seen on
any electrodes between groups 532 and 512, but grand
average (all electrodes) statistic calculation (Grand T532–
512) showed significant differences between the two
groups (p < 0.05). C-levels were considerably higher on
every electrodes in group 522 compared to groups 532
and 512, and the difference was significant for apical
electrodes 2 to 12 (p < 0.05, Fig. 4)a. Grand average (all
electrodes) statistic calculation (Grand T532–522) showed
significant differences between the groups (p < 0.05).
However, no significant difference was present on any
electrodes in C-levels 2 months after the first fitting,
only the grand average statistical analysis (Grand T532–
522) showed significant differences between groups 532
and 522 (Fig. 4)b.
Fig. 2 The mean postoperative C-levels in patient groups with different types of CI: Group 532 (n = 54, n = 54), group 512 (n = 54, n = 54) and group
522 (n = 51, n = 51) at first fitting (a) and 2-month follow-up fitting (b). The “*” stands for a significant difference between groups 532 and 522. Error
bars represent the standard deviation (SD). Grand T532–512 means statistical comparison between groups 532 and 512. Grand T532–512 means statistical
comparison between groups 532 and 522
Fig. 3 The mean intraoperative ESRT values in patient groups with
different types of CIs: group 532 (n = 44) and group 512 (n = 47).
The “+” means a significant difference between groups (a) and (b).
Error bars stand for the standard deviation (SD). „A” stands for
Nucleus CI532 and „B″ for Nucleus CI512 implants. Grand T532–512
means statistical comparison between groups 532 and 512
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Postoperative T-NRT
In group 532 and 512, T-NRT measurements were
attempted in all subjects at the two-month follow up fit-
ting and the measurements were successfully carried out
in 32 subjects in group 532 and 36 subjects in group
512. The intraoperative electrophysiological measure-
ments could be performed in all subjects under general
anesthesia, whereas the postoperative measurements
were performed in vigil subjects. In the latter case, some
of the subjects complained about unpleasant sound vol-
ume before a neural response could have been mea-
sured, for this reason the electrophysiological testing
cannot be performed.
Figure 4 shows the postoperative mean T-NRT values.
The mean T-NRT results in the basal section were lower
in group 532 than in group 512. The difference was sig-
nificant (p < 0.05) on two electrodes (No 14 and No 16).
Grand average (all electrodes) statistic calculation
(Grand T532–512) showed significant differences between
the groups (p < 0.05).
Discussion
A wide range of cochlear implants with different elec-
trodes are available for rehabilitation of hearing impaired
patients with severe to profound sensorineural hearing
loss. Hearing rehabilitation outcomes may be influenced
by optimizing device and electrode choice for the indi-
vidual. Several comparative studies have been conducted
including electrophysiological (ESRT, NRT) test
methods to evaluate the influence of straight and peri-
modiolar electrode designs and their in-situ characteris-
tics on clinical outcomes [1–3, 25–27]. Our study is
unique in that it measured the influence of various elec-
trode designs combined with a common receiver-
stimulator upon electrophysiological assessments for a
relatively large routinely treated multicenter study co-
hort. As such, it is the first study to report on the influ-
ence of electrode design while using consistent implant
receiver-stimulator electronics. The cooperation of the
two clinics was established in 2017 with the aim to com-
pare the perimodiolar and the straight electrode arrays.
The study clinics followed a standard protocol enabled
by the manufacturer’s software, thus a conclusion from
their individual results can be made. The results of Hey
et al. from their multicenter study on CI532 are in good
correlation with our results which proves that our meth-
odology and results are reliable [20].
The Contour Electrode was the first perimodiolar elec-
trode from Cochlear. As reported by researchers, some
intracochlear trauma has been associated with its insertion,
with a more reliable and less traumatic insertion achieved
when deployed using the recommended advance off-Stylet
technique [3]. This is largely due to an inherent reduction
in intracochlear outer wall force generation when using this
technique for this electrode [3].
The Slim Modiolar Electrode is designed for insertion
with minimal cochlear trauma. It has the advantage of
taking 60% less volume in the scala tympani compared to
the Contour Advance Electrode and is therefore placed in a
position close to the modiolus. Perimodiolar proximity is an
important clinical consideration as Holden et al. [15] con-
cluded, observing that total insertion depth was not associ-
ated with better speech discrimination outcomes, however,
the distance from the electrodes to the modiolus did indi-
cate a significant influence. The Slim Modiolar electrode
array takes a closer position to the modiolus than the Con-
tour Advance electrode array as confirmed by a comparative
radiological evaluation [21].
In this retrospective study the data from recipients
with the three main types of electrode arrays used in
each of the two author implant centers were included.
Although the electrode of CI522 was known to take the
lateral wall position within the cochlea, the authors’ de-
cided to enroll those subjects who were implanted with
CI522 to gain a more detailed overview. Although results
of two different implant centers were combined for
evaluation, upon review, the authors considered the rou-
tine clinical practices employed and device parameters
used at each site as sufficiently comparable.
Results from the objective intraoperative measurements
indicated that the electrode contacts of the CI532 array
were located closer to the modiolus than those of CI512.
A previous study found that withdrawal of the stylet in the
Contour Advance Electrode resulted in better NRT and
ESRT responses, than with the stylet in place. They con-
cluded that this is most probably due to a more favorable
position of the electrode array towards the modiolus
within the scala tympani once the stylet is removed [26].
Fig. 4 The mean postoperative T-NRT values in subject groups with
CI532 (n=32) and CI512 (n=36). The „+” represents a significant difference
between groups 532 and 512. Error bars represent the standard deviation
(SD). Grand T532–512 means statistical comparison between groups 532
and 512
Perenyi et al. Journal of Otolaryngology - Head and Neck Surgery           (2019) 48:46 Page 5 of 7
In our study, although the mean ESRT was only slightly
lower with CI532, the difference was statistically signifi-
cant at the basal most electrodes tested. However, the
mean T-NRT for CI532 was significantly lower than for
CI512, especially in the apical-middle section, which is
considered to be indicative of closer positioning towards
the modiolus. An expected rate of scalar dislocations
could be 26% with precurved electrode (i.e. CI512) and 3%
with straight electrode (i.e. CI522) with round window in-
sertion technique [28] and this dislocation should have a
significant impact on the NRT threshold in the apical part
of the electrode. In order to minimize scalar dislocation,
the extended round window insertion technique was used.
Although the institutional protocols did not include post-
operative computed tomography, the results from T-NRT
and ESRT, both being constantly higher for CI512 when
compared with CI532 and T-NRT being constantly lower
for CI512 when compared with CI522 are not indicative
of significant dislocations between scalae tympani and ves-
tibuli. The sizeable reduction in both T-NRT and ESRT
observed in our study are considered sufficiently large to
potentially influence differences in clinical outcomes as
observed for subjective comfort level [26, 29].
The surface area of an electrode is inversely propor-
tional with the resistance, thus current is proportional
with the surface area. If the electrode with a smaller sur-
face is capable of eliciting the same response it means
that it is closer to the stimulated structure. The lower
objective electrophysiological thresholds of CI532
suggest that the electrodes are capable of eliciting reflex
responses with lower stimulation intensity, resulting
from closer proximity to the modiolus.
Conclusion
Although the Slim Modiolar electrode is significantly thin-
ner than the Contour Advance and similar sized as the
Slim Straight electrode array, the Slim Modiolar electrode
provides similar or better stimulation productivity com-
pared to Contour Advance and Slim Straight electrodes.
The manufacturer’s thinnest electrode array, the Slim
Modiolar Electrode takes the position that is closer to the
modiolus compared to the Contour Advance Electrode
and the Slim Straight Electrode. Our intraoperative and
postoperative measurements confirmed this showing that
more effective stimulation can be achieved, through the
use of the Slim Modiolar Electrode.
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Cochlearis implantátumok különböző, 
előre görbített elektródasorainak 
elhelyezkedése a cochlea tengelyéhez 
viszonyítva
Radiológiai vizsgálat a perimodiolaritás mértékének 
megállapítására
Perényi Ádám dr.  ■  Nagy Roland  ■  Dimák Balázs 
Csanády Miklós dr.  ■  Jóri József dr. 
Kiss József Géza dr.  ■  Rovó László dr.
Szegedi Tudományegyetem, Általános Orvostudományi Kar, Fül-Orr-Gégészeti és Fej-Nyaksebészeti Klinika, 
Szeged
Bevezetés: A cochlearis implantátumok elektródái gyártótól és modelltől függően különböznek hosszukban, vastagsá-
gukban és implantációt követően a csiga tengelyéhez (modiolushoz) viszonyított elhelyezkedésükben. Az előre gör-
bített elektródasorok közelebb kerülnek a stimulálandó ganglion spirale sejtekhez, mint az egyenes elektródasorok, 
ami a stimulációban tapasztalt elektrofiziológiai különbségek mellett előnyös lehet a hangélmény minőségének szem-
pontjából.
Célkitűzés: Előzetes elektrofiziológiai vizsgálataink eredménye szerint ugyanannak a termékcsaládnak (Cochlear™ 
Nucleus® Profile) a vastagabb (Contour Advance) és vékonyabb (Slim Modiolar) perimodioláris elektródasorai közül 
a vékonyabbnak az elektródái hasonló töltésmennyiség átadása mellett is képesek hasonló idegi választ kiváltani, mint 
a vastagabbnak az elektródái. Vizsgálatunkkal arra kerestük a választ, hogy milyen jelenség áll az elektrofiziológiai 
eredmények hátterében.
Módszer: Betegcsoportonként 54, Contour Advance és Slim Modiolar típusú elektródasorral implantáltakat vontunk 
be. Az elektródasor bevezetése minden esetben a kerek ablakon keresztül történt, a kerek ablak elülső-alsó csontszé-
lének elfúrását követően vagy a nélkül. A műtét másnapján készült, Stenvers-féle röntgenfelvételeken megmértük az 
elektródasorok által leírt hurok cochleán belüli legnagyobb átmérőjét. A beültetés után két hónappal megbecsültük a 
kétféle perimodioláris elektródasorral felszerelt implantátum energiafelhasználási mutatóit.
Eredmények: A posztoperatív röntgenfelvételeken a vékonyabb perimodioláris elektródasorral implantált csoportban 
az elektródasorok által leírt hurok cochleán belüli átlagos átmérője 4,2 ± 0,5 mm, míg a vastagabb perimodioláris 
elektródasorral implantált csoportban 4,9 ± 1,1 mm értéknek adódott. Az ’Auto power’ a CI532-csoportban 44,81 
± 5,05%, a CI512-csoportban 50,85 ± 8,35% volt, tehát alacsonyabb energiafogyasztást tapasztaltunk a CI532-cso-
portban.
Következtetés: Képi diagnosztikai módszerrel, viszonylag nagy esetszám bevonásával arra következtettünk, hogy a 
vékonyabb perimodioláris elektródasor még a vastagabbnál is szignifikánsan közelebb kerül a modiolushoz, ami elfo-
gadható magyarázatot ad előzetes elektrofiziológiai mérési eredményeinkre.
Orv Hetil. 2019; 160(31): 1216–1222.
Kulcsszavak: siketség, cochlearis implantátum, elektródapozíció, modiolus, perimodioláris
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The distance from the modiolus of perimodiolar electrode arrays of cochlear 
implants 
A radiological study to evaluate the difference in perimodiolar properties
Introduction: The cochlear implants vary in electrodes in terms of length, width and proximity to the modiolus. The 
precurved electrode arrays could be placed closer to the modiolus and the ganglion cells compared to straight elec-
trodes. The two types of electrode arrays provide different electrophysiological characteristics; however, proximity to 
the modiolus may lead to better hearing performance.
Aim: To investigate our preliminary electrophysiological results that suggest that the Slim Modiolar (SM) electrode 
array has the potential to elicit similar neural responses as the thicker perimodiolar (Contour Advance, CA) electrode 
from the same generation of implants.
Method: Subjects that were implanted either with CA or SM electrodes were enrolled, 54 consecutive subjects in each 
group. All electrodes were introduced into the cochlea via the round window. The diameter of the largest turn of the 
electrode arrays within the cochlea was measured through postoperative radiography. The energy consumption pa-
rameters were estimated 2 months after implantation.
Results: The mean of the largest turns of the arrays within the cochlea was 4.2 ± 0.5 mm in the SM group and 4.9 ± 
1.1 mm in the CA group. ‘Auto power’ was 44.81 ± 5.05% and 50.85 ± 8.35% with SM and CA, respectively. Esti-
mated energy consumption was lower with SM. The differences were statistically significant.
Conclusion: Our measurements for a large cohort in each group suggest that the SM electrode array takes a signifi-
cantly closer position to the modiolus than the CA. This finding supports our earlier electrophysiological result and 
indicates better performance abilities.
Keywords: deafness, cochlear implant, electrode position, modiolus, perimodiolar
Perényi Á, Nagy R, Dimák B, Csanády M, Jóri J, Kiss JG, Rovó L. [The distance from the modiolus of perimodiolar 
electrode arrays of cochlear implants. A radiological study to evaluate the difference in perimodiolar properties]. Orv 
Hetil. 2019; 160(31): 1216–1222.
(Beérkezett: 2019. február 21.; elfogadva: 2019. március 25.)
Súlyos fokú sensorineuralis halláscsökkenés esetében, 
amikor nagy teljesítményű hallókészülékkel sem valósít-
ható meg kielégítő hallás(re)habilitáció, cochlearis im-
plantátum beültetése lehet indokolt. Több gyártó kínál 
belsőfül-implantátumot és többféle beszédprocesszort, 
és egyazon gyártótól is több konfiguráció áll rendelke-
zésre. A konfigurációk különböznek az elektródasorok 
típusában (például egyenes vagy előre görbített, teljes 
hosszúságú vagy rövid, vékony vagy vastag), ezáltal lehe-
tőséget biztosítanak a páciensek egyéni anatómiai tulaj-
donságaira és igényeire szabott eszköz megválasztására. 
A variációk ugyanakkor megnehezítik a klinikai vizsgála-
tok eredményeinek összehasonlítását, értékelését. Több 
kutatócsoport végzett célzott vizsgálatokat a különböző 
elektródasorok tulajdonságaiból adódó gyakorlati követ-
kezmények felmérésére, így például a stimuláló elektró-
dasornak a cochlea tengelyéhez, azaz a modiolushoz vi-
szonyított távolságára [1, 2] és ennek elektrofiziológiai 
hatásaira [3], az energiafogyasztásra, az endocochlearis 
struktúrák sérülésének mértékére [4], a lehető legkisebb 
traumával járó sebészi technikákra [2, 5–7], a kombinált 
elektroakusztikus stimulációra [8, 9] és a hallásmarad-
vány megőrzésére [10–14] vonatkozóan. A megfelelő 
hangélmény biztosítását a tudományos közlemények 
szerzői elsősorban az elektródasor tulajdonságaiban, az 
elekródasor kíméletes bevezetésében és a beszédprocesz-
szor jó beprogramozásában látják. Egyes szerzők az elő-
re hajlított elektródasorok modiolushoz közeli helyzeté-
vel, míg mások a cochlea hosszú elektródasor általi teljes 
lefedettségével tapasztaltak jobb eredményeket a hal-
lásélményben [15–18]. 
Az elektródasorok a cochleán belül, típustól függően 
két „szélső pozícióba” kerülhetnek: az egyenes elektró-
dasorok a modiolustól távoli, ún. laterális fali helyzetet, 
míg az előre görbített elektródasorok modiolushoz kö-
zeli, ún. perimodioláris helyzetet foglalnak el (1. ábra). 
Létezik még az úgynevezett midscala elhelyezkedésű 
elektródasor, amely a scala tympaniba vezetve „köztes” 
pozíciót vehet fel.
Bár vitatott dolog, hogy az egyenes vagy az előre gör-
bített elektródasorokkal érhető el jobb hallásélmény, a 
stimuláló elektródák és a modiolus viszonyának fontossá-
gára mutat rá az a vizsgálati eredmény, amely szerint a 
hangélmény és a beszédértés minőségében szignifikáns 
javulást eredményezhet, ha az elektródák közelebb ke-
rülnek a modiolushoz, előre görbített elektródasorok 
esetében [15]. Az előre görbített elektródasorok előnye 
az egyenesekkel szemben az, hogy kialakított tulajdonsá-
guknak köszönhetően az egyes elektródák közelebb ke-
rülhetnek a modiolushoz, ezáltal az elektromosan stimu-
lálandó ganglion spirale sejtekhez is. Következésképpen 
a leadott töltésmennyiség – a kisebb távolság miatt – ki-
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sebb mértékben szóródik szét a cochlea folyadékterében, 
így kisebb áramerősségű impulzusok elegendőek a gang-
lion spirale sejtjeinek ingerléséhez [14, 19, 20]. Emiatt 
szélesebb a hallásküszöb és a komfortküszöb közötti di-
namikai tartomány, csökken az energiafogyasztás, és nő 
az elem/akkumulátor életideje [1, 21].
Cochlearis implantátum beültetését követően rutin-
szerűen röntgenfelvételt készítünk. A Stenvers-féle felvé-
telen nagy biztonsággal állapíthatók meg azok a kompli-
kációk, amelyek az elektródasor eltávolítását és újbóli 
pozicionálását teszik szükségessé, így például ha az elekt-










Slim Straight elektródasor Slim Modiolar elektródasor
1. ábra Az egyenes és a perimodioláris elhelyezkedésű elektródasorok cochleán belüli helyzetének szemléltetése ugyanannál a páciensnél, szekvenciális coch-
learis implantációt követően, Stenvers-szerinti röntgenfelvételeken. A jobb és a bal oldali cochlea szabályos alakú és azonos méretű, amit az implantá-
ciókat megelőzően készült komputertomográfiás felvételen, méréssel ellenőriztünk. A jobb cochleába vékony, egyenes stimuláló elektróda (Cochlear™ 
Slim Straight), a bal cochleába vékony, előre görbített stimuláló elektróda (Cochlear™ Slim Modiolar) került. A szaggatott fekete kettős nyilak az 
elektródasorok által a cochleán belül leírt hurok legnagyobb átmérőjét mutatják
2. ábra Cochlearis implantációt követően 15 évvel, recidiváló cholesteatoma gyanúja miatt készített cone-beam komputertomográfiás vizsgálat, modiolusra 
centrált, rá merőleges síkú, a cochlea bazális kanyarulatát ábrázoló rekonstrukciója. A cochleában kiterjesztett kerek ablaki behatolásból bevezetett 
Contour Advance elektródasor látható. A dobüregben – hipodenz megjelenésű levegő helyett – lágyrésznek megfelelő fedettséget (műtéti leletünk 
alapján recidív cholesteatomát és hegeket) találunk. Elkülöníthető a csontos cochleán belül a hártyás cochlea, és látható, hogy az előre görbített elekt-
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vagy a vékony, előre görbített elektródasorok esetében 
gyakran észlelt ’tip fold-over’ (az elektródasor csúcsi ré-
szének visszahajlása) [22, 23]. A szummációs röntgenké-
peken a csigán belüli részletek (scala tympani, scala vesti-
buli) nem különülnek el. Komplikáció gyanújakor, a 
részletgazdagabb képi megjelenítés érdekében szóba jön 
a sziklacsont vékony szeletes komputertomográfiás (CT-) 
vizsgálata vagy még inkább cone-beam (kúpsugaras) CT-
vizsgálata, amely szignifikánsan alacsonyabb effektív su-
gárdózissal elvégezhető, és kevesebb műterméket okoz-
nak rajra a fémelektródák (2. ábra) [24–26]. 
A hallásmaradvány implantációt követő megőrzésének 
kiemelten fontos feltétele az, hogy az elektródasor mind 
a bevezetésekor, mind azt követően a lehető legkisebb 
traumát okozza a cochleában. Ezért alkalmazunk vé-
kony, hajlékony elektródasorokat, amelyeket az ún. soft 
surgery [27] technikával vezetünk a cochlea scala tympa-
ni járatába. A rendelkezésre álló vékony elektródasorokat 
az 1. táblázatban mutatjuk be [28–32]. 
A klinikai vizsgálatok eredményeinek értékelését meg-
nehezítő variációk csökkentése érdekében ugyanannak a 
termékcsaládnak kétféle előre görbített elektródasorral 
rendelkező implantátumtípusát választottuk a vizsgála-
tunkhoz. Munkacsoportunk rendszeresen alkalmazza a 
Cochlear™ Nucleus® Profile termékcsaládot (Cochlear 
Limited, Sydney, Ausztrália), és széles körű tapasztalatra 
tett szert mindkét perimodioláris elektródával. A ter-
mékcsalád tagjai csupán az elektródasor típusában kü-
lönböznek, az implantátumtestben elhelyezkedő elekt-
ronikai egység azonos. A Slim Modiolar a jelenleg 
elérhető egyik legvékonyabb elektródasor, amely 
 ’closed-market release’ (zárt piaci kibocsátás) keretében 
a Szegedi Tudományegyetem Fül-Orr-Gégészeti és Fej-
Nyaksebészeti Klinikáján került beültetésre elsőként, 
2015 novemberében. A Contour Advance® elektródasor 
mind az apicalis, mind a bazális átmérőjében (a: 0,5 mm, 
b: 0,8 mm) szignifikánsan vastagabb a Slim Modiolar 
elektródasor átmérőinél (a: 0,4 mm, b: 0,5 mm), és az 
egyes elektródák aktív felülete nagyobb, mint a Slim Mo-
diolar elektródáké [31, 32]. Mivel az ingerlő elektródák 
felszíne és az ellenállás között fordított arányosság áll 
fenn, valamint az ingerlő elektródák és a célzott idegele-
mek (modiolus, ganglion spirale) közötti távolság egye-
nesen arányos a közeg elektromos ellenállásával, ebből az 
következik, hogy ha a kisebb felszínű elektródák kisebb 
töltésmennyiséggel képesek lehetnek kiváltani hasonló 
mértékű akciós potenciált, akkor közelebb kell lenniük a 
stimulált struktúrához.
Munkacsoportunk korábbi, nagy esetszámon elvég-
zett elektrofiziológiai vizsgálatainak eredményei arra 
utalnak, hogy ugyanazon elektronikai egység mellett a 
Slim Modiolar elektródasor (CI532 típusú implantátum) 
még alacsonyabb áramerősségű impulzusok mellett is 
képes idegi választ, akciós potenciált generálni, mint a 
Contour Advance elektródasor (CI512 típusú implantá-
tum) [33, 34]. Vizsgálatunk célja annak megállapítása 
volt, hogy a fenti előnyös elektrofiziológiai tulajdonsá-
gokból levont következtetést alátámasztják-e az implan-
tátum energiafelhasználási mutatói és a posztoperatív 
képalkotó vizsgálatok eredményei.
Anyag és módszer
Az első 54, CI532 és az első 54, CI512 készülékkel im-
plantált esetünket vizsgáltuk. A betegcsoportok demog-
ráfiai jellemzőit a 2. táblázatban tüntettük fel. 
A műtéteket két, cochlearis implantációban jártas, ta-
pasztalt fülsebész végezte el a nemzetközileg leginkább 
elfogadott és elterjedt módszerrel, posterior tympanoto-
miás feltárásból, „soft surgery” technikával a Szegedi 
Tudományegyetem Szent-Györgyi Albert Klinikai Köz-
pontja Fül-Orr-Gégészeti és Fej-Nyaksebészeti Kliniká-
ján. Az elektródasorok bevezetése a kerek ablak fülkéjét 
(fossula fenestrae cochleae) képező csontos struktúrák 
elvétele után a kerek ablakon keresztül vagy járulékosan 
a kerek ablak elülső-alsó csontszélének elfúrását követő-
en, ún. kiterjesztett, kerek ablaki behatolásból történt.
1. táblázat A vékony elektródasorok típusa és átmérői [28–32]
Elektródasor 
megnevezése
Elektródasor típusa Elektródasor átmérője 
(a: apicalis, b: bazális)
MED-EL FLEX24 és 
FLEX28
Egyenes a: 0,3 × 0,5 mm 
b: 0,8 × 0,8 mm [28]
Advanced Bionics 
HiFocus™ Mid-Scala
Előre görbített a: 0,5 mm 
b: 0,7 mm [29]
Oticon Medical 
EVO® 
Egyenes a: 0,4 × 0,4 mm 
b: 0,5 × 0,5 mm [30]
Cochlear™ Nucleus® 
Profile Slim Straight
Egyenes a: 0,3 mm
b: 0,6 mm [31]
Cochlear™ Nucleus® 
Profile Slim Modiolar 
(CI532)
Előre görbített a: 0,35 × 0,4 mm 
b: 0,45 × 0,5 mm [32]
2. táblázat A vizsgálatba bevont betegek demográfiai adatai
Betegcsoport CI532 CI512











Az implantált fülek száma 54 54
Életkor (év) 25,17 ± 26,29 20,80 ± 25,87
Nem (férfi/nő) 25/29 23/31
A siketség időtartama (év) 2,94 ± 7,46  3,06 ± 9,34 
A siketség oka  
     veleszületett 29% 28%
     progresszív 22% 26%
     ismeretlen 16% 28%
     egyéb 33% 17%
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Az első posztoperatív napon protokollunknak megfe-
lelően digitális röntgenfelvétel készült Stenvers-nézet-
ben [35] a beültetett implantátum helyzetének meghatá-
rozására. Jellemeztük az elektródasor és a modiolus 
viszonyát: a 3. ábrán feltüntetett módon a modiolus ten-
gelyére állított merőleges egyenesen megmértük az 
elektródasor által leírt hurok cochleán belüli legnagyobb 
átmérőjét. Összehasonlítottuk az elektródahurkok ezen 
átmérőit a két betegcsoportban. A statisztikai értékelést 
kétmintás t-próbával végeztük. 
A beültetést követően két hónappal, ugyanannak a be-
szédprocesszornak (Cochlear™ Nucleus® CP910) az 
alkalmazása mellett, a készülék beprogramozása után 
megbecsültük a kétféle perimodioláris elektródasorral 
rendelkező implantátum energiafelhasználási mutatóit a 
Cochlear™ Custom Sound® Suite 4.4 verziójú szoftver-
rel.
Eredmények
A posztoperatív röntgenfelvételeken a CI532-betegcso-
portban az elektródahurok cochleán belüli átlagos átmé-
rője 4,2 ± 0,5 mm SD, míg a CI512-betegcsoportban 
4,9 ± 0,1 mm SD volt (kétmintás t-próba: p = 0,00136) 
(3. ábra).
Egyik páciensünk esetében két különböző elektróda-
sorral végeztünk szekvenciális bilaterális implantációt: 
jobb oldalra CI512 típusú, bal oldalra CI532 típusú 
implantátumot ültettünk be másfél év különbséggel. Az 
elektródák perimodioláris elhelyezkedését találtuk mind-
két oldalon, ugyanakkor a Slim Modiolar elektródasor-
nak kisebb a cochleán belüli hurokátmérője.
’Tip fold-over’-t a vizsgált 108 esetünkben nem talál-
tunk.
Az ’Auto power’ szint szignifikánsan alacsonyabbnak 
bizonyult a CI532-betegcsoportban (44,81 ± 5,05%), 
mint a CI512-betegcsoportban (50,85 ± 8,35%) 
(p<0,05). Nagyobb ’maximaértékek’ (7,50 ± 0,87 versus 
6,56 ± 1,02) mellett is hosszabb az akkumulátor becsült 
életideje (napi élettartama) a vékonyabb perimodioláris 
elektródasor esetében (3. táblázat).
Megbeszélés
A nagyfokú halláscsökkenésben szenvedő páciensek 
 (re)habilitációjára több gyártó különféle elektródasorok-
3. ábra Perimodioláris elektródasorok helyzete a cochleán belül, ugyanannál a páciensnél, szekvenciális cochlearis implantációt követően, Stenvers szerinti 
röntgenfelvételeken. A jobb és a bal oldali cochlea szabályos alakú és azonos méretű, amit az implantációkat megelőzően készült komputertomográ-
fiás vizsgálaton ellenőriztünk. A jobb cochleába a vastagabb előre görbített stimuláló elektródasor (Contour Advance), a bal cochleába a vékonyabb 
előre görbített elektródasor (Slim Modiolar) került. A szaggatott fekete vonalak az elektródasor által a cochleán belül leírt hurok legnagyobb átmérő-
jét mutatják
Contour Advance elektródasor Slim Modiolar elektródasor






3. táblázat Ugyanannak az implantátumcsaládnak a vékonyabb (Slim Mo-
diolar) és vastagabb (Contour Advance) perimodioláris elektró-
dasorával rendelkező implantátumok energiafelhasználási muta-
tói ugyanazzal a típusú beszédprocesszorral




44,81 ± 5,05% Auto power 50,85 ± 8,35%
  7,5 ± 0,87 Maxima  6,56 ± 1,02
43,25 ± 8,46 h Battery 40,04 ± 6,48 h
19,56 ± 1,82 h Standard accu 18,04 ± 2,52 h
11,5 ± 1,15 h Compact accu 10,58 ± 1,51 h
 
Auto power: A készülékprogramozáshoz szükséges gyártói szoftver le-
hetővé teszi a teljesítmény automatikus vagy manuális konfigurálását 
minden egyes paraméterezett beállításhoz, úgynevezett MAP-hez. 
Ajánlott az Auto power funkció használata minden lehetséges esetben, 
amely hozzájárul a hangprocesszor teljesítményszintjének automatikus 
optimalizálásához. Miután meghatároztuk az egyes készülékbeállítás-
hoz szükséges paramétereket, úgy az automatikusan számított teljesít-
ményszint megjelenik a MAP-eken.
Maxima: A maximaérték az egyes beszédkódolási stratégiák paraméte-
re (SPEAK, az ACE™ és az MP3000™); az audiojel azon spektrális 
felbontás után frekvenciatartományaira utal, amelyek a legnagyobb 
hangerősséggel rendelkeznek. Ez az érték adja meg az adott jelhez ki-
választott maximaértékek számát, tehát adott időpillanatban a maxima-
értéknek megfelelő számú legnagyobb hangerősséggel bíró, aktív 
elektródák számát.
Battery: hagyományos elem, vagyis kettő darab, 675 típusszámú, 1,45 
V gombelem. 
Standard accu: hagyományos akkumulátor.
Compact accu: kompakt akkumulátor, kisebb a hagyományos akkumu-
látornál.
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kal ellátott cochlearis implantátuma áll rendelkezésre. A 
hallás(re)habilitáció eredményeire kihat a készülék és az 
elektróda egyénre szabott megválasztása. A perimodiolá-
ris elektródák modiolushoz minél közelibb elhelyezke-
désének fontosságára hívja fel a figyelmet Holden és mun-
katársainak 2013-ban publikált eredménye, amely 
szerint a páciensek hangélményének és beszédértésének 
minősége elsősorban nem a bevezetett elektródasor 
hosszától, illetve a bevezetés mélységétől függ, hanem az 
elektródasor modiolushoz viszonyított helyzetétől [15].
A Contour Advance olyan, előre görbített elektróda-
sor, amelyet belső fém vezetőszál segítségével, kiegyene-
sített állapotban vezetünk be a cochlea scala tympani 
 járatába. Az ’advance off-stylet’ technika jelentős ered-
ményeket hozott az endocochlearis struktúrák sérülésé-
nek csökkentésében, ez az elektródasor a vastagsága és a 
fém vezetőszál miatt mégis nagyobb arányban okoz sé-
rülést, mint a vékonyabb egyenes elektródasorok [2]. A 
cochleában okozott sérülések csökkentésére fejlesztették 
ki a szintén előre görbített, vékony és kevésbé merev 
Slim Modiolar típusú perimodioláris elektródasort, ame-
lyet külső vezetőhüvely segítségével vezetünk be a coch-
leába. Az utóbbi a scala tympani folyadékteréből jelentő-
sen kisebb volument foglal el a vastagabb elektródasorhoz 
képest, és azt is döntően a bazális membrán csontos ré-
sze alatt, ami kevésbé zavarja a cochlea hidrodinamikai 
működését. Fontos ez a körülmény a műtét előtti hallás-
maradvány megőrzésének lehetősége szempontjából 
[14].
A pácienseinkről rendelkezésre álló posztoperatív digi-
tális röntgenfelvételekről határoztuk meg a stimuláló 
elektródák cochleán belüli helyzetét. Cone-beam CT-vel 
(2. ábra), rotációs tomográfiával vagy vékony szeletes 
CT-vizsgálattal részletgazdagabb képeket, ezáltal az 
egyes esetekben pontosabb távolságmérési adatokat kap-
hatnánk [24–26, 36]; ezeknek a vizsgálatoknak lényege-
sen nagyobb a pácienst érintő sugárterhelésük (effektív 
dózisuk), mint a koponya-röntgenfelvételeké, és korláto-
zottabban juthatunk hozzájuk a mindennapi ellátásban. 
Ugyanakkor a standardizált protokollnak köszönhetően 
a direkt digitális röntgenfelvételeken [34] is jól megálla-
pítható a különböző elektródákkal implantált betegcso-
portok közötti különbség, nagy esetszám mellett. Sten-
vers-felvételen a centrális sugárnyaláb a cochleán hatol 
keresztül, így a röntgentechnika sajátosságaként ismert 
nagyítás és torzítás szerepe minden vizsgálatnál csak egy-
formán kis, gyakorlatilag elhanyagolható mértékben je-
lentkezik. A szummáció szintén elhanyagolható a fém 
(elektróda), a csont és a lágyrészek eltérő sugárelnyelő 
képessége miatt. A páciensek életkorbeli különbségei a 
képalkotó vizsgálatok szempontjából elhanyagolhatók, 
mivel a belső fül méretei már a születéskor megegyeznek 
a felnőttkori méretekkel [37–39].
A fenti vizsgálatainkkal szignifikáns különbséget talál-
tunk a kétféle perimodioláris elektródasor cochleán belü-
li hurokátmérőjében és az energiafelhasználási mutatók-
ban, a vékonyabb elektródasor javára.
Következtetés
Képi diagnosztikai módszerrel, nagy esetszámon megál-
lapítottuk, hogy ugyanazon termékcsalád vékonyabb 
perimodioláris elektródasora a vastagabb perimodioláris 
elektródasornál szignifikánsan közelebb kerül a modio-
lushoz. A CI532 energiafelhasználási mutatói jobbak a 
CI512 mutatóinál, tehát a vékonyabb perimodioláris 
elektródával alacsonyabb energiafelhasználás mellett is 
ugyanolyan hatékonyan stimulálható a hallóideg (3. táb-
lázat).
Az elektródasor megválasztásának fontos szempontjait 
(a hallásélmény, a beszédértés javítása, a hallásmaradvány 
megőrzése) figyelembe véve munkacsoportunk a peri-
modioláris elektródasorok közül a vékonyabb perimodi-
oláris elektródasor alkalmazását tartja megfelelőnek és 
kívánatosnak.
Anyagi támogatás: A közlemény megírása, illetve a kap-
csolódó kutatómunka anyagi támogatásban nem része-
sült. 
Szerzői munkamegosztás: P. Á.: A protokoll kidolgozása, 
a mérések elvégzése, a kézirat megszövegezése. N. R., 
D. B.: Az elektrofiziológiai vizsgálatok elvégzése, a kéz-
irat megszövegezése. Cs. M.: A kézirat megszövegezése. 
J. J.: Műtétek végzése, a kézirat megszövegezése. K. J. 
G.: A mérési módszer kidolgozása, statisztikai elemzés. 
R. L.: A protokoll kidolgozása, műtétek végzése, a kéz-
irat megszövegezése. A cikk végleges változatát vala-
mennyi szerző elolvasta és jóváhagyta.
Érdekeltségek: A szerzőknek nincsenek érdekeltségeik.
Köszönetnyilvánítás
A szerzők köszönetet mondanak a Szegedi Tudományegyetem Szent-
Györgyi Albert Klinikai Központja Radiológiai Klinikájának és az Affi-
dea Diagnosztika Kft.-nek a radiológiai vizsgálatok kiváló minőségben 
történt elvégzéséért.
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Abstract
By using sophisticated surgical techniques in combination with the Slim Perimodiolar cochlear 
implant electrode array a hitherto unattained high rate of residual hearing preservation in cochlear 
implantation has been observed that makes potential for electric acoustic stimulation. One of the 
primary aims of cochlear implant system engineering is to promote atraumatic electrode insertion 
to maintain optimal postoperative hearing sensitivity by protecting and preserving the delicate 
inner ear structures.
The study aimed to collect pre-, and postoperative audiological and surgical results from the 
experience gained from the applied cochlear implant configuration.
About 30 patients (aged 43.32 ± 24 years) with partial hearing loss were supplied with this atraumatic 
perimodiolar thin electrode which was designed to preserve residual hearing despite intracochlear 
insertion of an electrode array. All patients were implanted with consentaneous CI system and 
surgery technique.
The use of new electrode array profiles in cochlear implantation plays a fundamental role in 
minimally invasive soft surgery, taking into individual needs, and providing long-term acoustic 
hearing preservation. Hearing preservation was achieved in most cases (partial residual hearing 
preservation) after a long-term follow-up period (preoperation, at least one year).
Keywords: Cochlear implantation; Hearing preservation; Soft surgery; Perimodiolar electrode 
profile
Introduction
Competing companies (Advanced Bionics, Cochlear, Med-El and Oticon, etc.) provide different 
types of receiver-stimulators, implant electrodes and speech processors. There are several pros and 
cons when opting for an electrode profile (straight or perimodiolar), cochlear coverage (total or 
partial), receiver-stimulator (physical attributes) and speech processor (electric or electroacoustic 
stimulation), that meet the individual needs. One of the primary aims of cochlear implant system 
engineering is to promote atraumatic electrode insertion to maintain optimal postoperative hearing 
sensitivity by protecting and preserving the delicate inner ear structures.
Residual hearing sensitivity may deteriorate due to perioperative traumas or complications with 
delayed onset. The applied surgical approach (Round Window (RW), Extended Round Window 
(ERW), Cochleostomy (CS)) and the implanted electrode profile mainly lead to immediate or short-
term damage, while delayed alteration in cochlear function usually derives from the fibrous or bony 
remodelling of the endocochlear compartments.
Surgically important properties are the physical attributes of the electrode configuration 
(perimodiolar vs. straight; rounded vs. smoothened tip; short vs. regular; with or without stylet, 
etc.), the type of cochlear fenestration (RW, ERW, CS), the method of electrode insertion (standard 
vs. soft surgery with advance-off-stylet), the use of lubricants or drugs in the cochlea (e.g. intrascalar 
corticosteroids) and the intrascalar position of the electrode array (perimodiolar, mid-scala, lateral-
wall) [1-3].
However, the possible disproportion between the physical dimensions of the electrode profile 
and the endocochlear compartments (diameter, shape, length of scala tympani) play a significant 
role in preserving inner ear structures and functions, too.
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Minimizing the damage in the inner ear enhances the possibility 
for hearing preservation, thus leading to better hearing performance. 
Systemic and/or intratympanic administration of steroids may 
contribute to hearing preservation. The beneficial effects of 
glucocorticoids are thought to be mediated through several different 
pathways: the anti-inflammatory effects; the down-regulation of 
production of inducible nitric-oxide synthase; and direct inhibition 
of the MAP/JNK cell death signal cascade [2-5].
We aimed to study long-term hearing preservation in a non-
randomized, prospective clinical cohort with cochlear implant 
systems, limited to ones produced by Australian and Austrian leader 




Out of the total number of cochlear implantees with slim 
perimodiolar implant system (n=94) our study population was 
recruited on the basis of the following criteria: (1) patient with good 
compliance; (2) measureable preoperative hearing threshold; (3) slim 
perimodiolar electrode array implant system; (4) minimum one-year 
follow-up period. Thirty consecutive subjects were enrolled into this 
prospective, non-randomized clinical study. Twenty females and ten 
males with mean age at implantation of 43.32 years, ranged between 
10 years to 77 years. All subjects were implanted at the University of 
Szeged from 2015 until 2017. The postoperative follow-up duration 
lasted 1.72 years at average (ranged between 1.1 and 2.55 years). All 
subjects met the official indication criteria of Cochlear Implantation 
(CI). Anatomical / structural malformation was not revealed by the 
preoperative radiological examinations. For detailed patient data, 
please see Table 1.
Implant configuration
The studied cochlear implant system has a slim, full-length 
perimodiolar electrode (Figure 1). The thin implant body has no 
pedestal and it is designed to minimize bone excavation and skin 
protrusion. At the implant coil the implant measures 3.7 mm and the 
implant main body measures 3.9 mm in thickness. The side-by-side 
symmetrical shape makes the implantation easier for the surgeon. 
The titanium casing has been used for high impact resistance, and 
the smooth external geometry to minimize biofilm formation, that 
reduces the risk of infection. The 98 mm total length of electrode 
array helps to insert it in a better position, but the main handle assist 
tool is the reloadable sheath for the smooth electrode insertion. The 
thin electrode array allows unobstructed access to the scala tympani 
that has a tip diameter of 0.35 × 0.4 mm and 0.45 × 0.5 mm at the 
base. At the last edge of the electrode array there are three white 
marker rings for controlling the insertion depth that are followed by 
22 half banded platinum electrode contacts. These properties make 
this implant configuration easier to use with shorter incision and 
surgery time. The insertion assistant sheath platform and the physical 
attributes of the electrode array facilitate to proximate the modiolus 
and thus prevent the electrode from dislocation into the scalae media 
or vestibuli [6-8].
Surgical technique
Preserving the residual hearing requires minimally invasive 
techniques of (1) cochlear fenestration, (2) management of 
endocochlear fluid compartments and (3) atraumatic electrode 
insertion, known as soft surgery. Thinner and atraumatic electrode 
arrays are also designed to accomplish these aims, as postoperative 
hearing performance can be maximized by minimizing the insertion 
trauma [3,8-11].
Several important factors contribute to intracochlear damage 
during implantation: (1) direct physical trauma, (2) pressure 
wave propagation in the perilymphatic fluid, (3) vibration and/
or heat trauma from drilling, (4) loss of perilymph, (5) changes 
Figure 1: (A) A traumatic electrode insertion in optimal position with the 
reloadable sheath. (B) Slim, perimodiolar electrode configuration with total 
cochlear coverage.
Figure 2: Skull AP axial on the first postoperative day that confirms the 
proper in situ electrode position. The depicted subject (not included into the 
present study due to completely missing preoperative hearing) was chosen 
to interpret the differences between sequentially implanted systems (A: 
right ear: CI512 Contour Advanced; B: left ear: CI532 Slim Perimodiolar). 
A decreased electrode array curvature is seen with the slim perimodiolar 
system (B).
Figure 3: Number of implantees with measurable hearing threshold at 
different frequencies. Preoperative (striped pattern columns); postoperative 
(checked pattern columns). On the top horizontal axis, the frequency-specific 
success rate of hearing preservation is showed in percentages.
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in homeosthasis/hydrodynamics of the endocochlear fluid 
compartments, (6) delayed fibrotic alteration and new bone formation 
within the cochlear lumen [3,12-16].
The physical attributes (length and diameter) of the electrode 
array may each limit the postoperatively achieved residual hearing 
[17].
Comprehensive analysis of imaging diagnostics of the middle and 
inner ear provide indispensable information for planning the proper 
surgical access route and electrode [17,18].
Soft surgery
The term soft surgery was introduced by Lehnhardt in 1993 and it 
provided basis for numerous publications [9,19].
Our routinely applied minimally invasive surgical technique 
involved electrode insertion via the Round Window (RW). In order 
to reduce bleeding and to prevent blood from accessing the cochlea, 
we filled the tympanic cavity with adrenaline solution after having the 
posterior tympanotomy been completed. To prevent bone fragments 
entering the cochlea, the tympanic and mastoid cavity were flushed 
with abundant amount of saline. To remove the bony overhang of 
the round window, we used a 1 mm diamond burr at low speed (max. 
350 rpm) in order to avoid noise and heat injury. We opened the RW 
membrane with a microscopic needle or hook. After opening the 
inner ear, suction was applied with care in order to avoid reducing 
the amount of perilymph. Furthermore, the scala tympani was left 
open for the shortest possible period, to prevent bone fragments, 
blood or other substances entering the inner ear, which might have 
been sources of primary and/or secondary injuries that finally would 
lead to loss of residual hearing. As a sort of prevention, after having 
opened the RW, we placed a piece of gel-foam soaked in corticosteroid 
solution into the RW niche.
The slim modiolar electrode of the CI532 implant was soaked 
into methylprednisolone solution (40 mg powder dissolved in 10 ml 
saline) and it was retracted into the insertion sheath. The insertion 
sheath together with the electrode array was inserted into the scala 
tympani with the lowest possible force. Any minute resistance felt by 
the surgeon would have indicated physical contact of the electrode 
array to the basilar membrane or the lateral wall of the scala tympani 
or stria vascularis and possible injury of these structures. After the 
electrode had been inserted in full length, indicated by the 1st marker 
ring, the RW was immediately sealed with an autologous tissue (e.g. 
fascia or muscle) in order to prevent loss of perilymph [9].
Radiological validation
Radiography (skull AP axial/Towne view) was performed on the 
first postoperative day to confirm the proper intracochlear electrode 
position (Figure 2).
Pure-tone audiometry
Pure-tone air-conduction thresholds were used to register 
residual hearing with the ascending method, with 5 dBHL intensity 
steps. The audiometer (GSI 61 Clinical Audiometer; Grason-
Stadler, MN USA) was calibrated according to the standards of the 
International Organization for Standardization (ISO 389-1:2017). 
THD-50P (Telephonics Corporation/Griffon Company, NY USA) 
headphone was used for air conduction hearing measurements.
Results
Pre- and postoperative pure tone hearing threshold 
measurements were completed for all the 30 recruited subjects. Figure 
3 frequency-dependently illustrates the number of patients pre- and 
postoperatively, where hearing sensitivity was measurable. It is well 
demonstrated that hearing is the most stable within the 250 to 1000 
Hz range, and the least is beyond 4 kHz. This statement is true either 
pre-, or postoperatively.
Figure 4: Preoperative (striped pattern columns) and postoperative (dotted 
pattern columns) hearing thresholds in dBHL at the measured frequencies 
(*p<0.05).
Figure 5: Loss of acoustic sensitivity interpreted in dBHL ranges, while 
exhibiting the number of implantees frequency-specifically (with different 
patterns of columns).
Figure 6: Preoperative threshold of HP (striped pattern columns, n=number 
of patients) and THL (squared pattern columns, m=number of patients) 
patients (Continuous line measureable threshold level).
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The average preoperative thresholds of the hearing within the 
lower frequency range were 61.75 dBHL at 125 Hz (no response from 
10 patients); 78.52 dBHL at 250 Hz (no response from 3 patients). At 
the middle frequency range, mean values were 88.67 dBHL at 500 Hz 
(response from all patients); 97.07 dBHL at 1 kHz (no response from 
1 patient) and 100.50 dBHL at 2 kHz (no response from 10 patients). 
At the higher frequencies, the average values were 91.36 dBHL at 4 
kHz (no response from 19 patients) and 84.00 dBHL at 8 kHz (no 
response from 25 patients).
The difference in height between the striped and checked pattern 
columns represents the percentage of successful hearing preservation 
at specific frequencies.
One year postoperatively the average values of the hearing 
thresholds at the lower frequency range were: 93.89 dBHL at 125 Hz 
(no response from 17 patients); 87.86 dBHL at 250 Hz (no response 
from 10 patients). At the middle frequencies mean values were 102.86 
dBHL at 500 Hz (no response from 10 patients); 111.61 dBHL at 1 
kHz (no response from 14 patients) and 113.75 dBHL at 2 kHz (no 
response from 21 patients). At the higher frequencies, average values 
were 115.18 dBHL at 4 kHz (no response from 24 patients) and 99.29 
dBHL at 8 kHz (no response from 29 patients).
Figure 4 illustrates the preoperative (striped pattern columns) 
and the postoperative (dotted pattern columns) hearing thresholds 
in dBHL at the measured frequencies. Decrease was detected at each 
examined frequencies but the grade of it varied. The highest decrease 
was measured at 500 Hz with an average decrease of 14.19 dBHL and 
at 1000 Hz with an average decrease of 13.77 dBHL. At the lower 
frequency range, hearing remained substantially stable. At 125 Hz 
only 3.06 dBHL, while at 250 Hz only 7.19 dBHL loss was detected. At 
the high frequencies, from 2 to 8 kHz preoperative hearing sensitivity 
had been already proved to be rather poor, thus further loss had just 
little consequences.
Figure 5 frequency-specifically demonstrates the degree of loss of 
acoustic sensitivity grouped into dBHL ranges, while exhibiting the 
No. Gender Age (year) Implanted ear
Hearing Loss w/wo genetic 
origin
Total Hearing Loss (THL) after implantation
1 Male 55 Left No No
2 Male 59 Left Yes Yes
3 Male 16 Right No No
4 Male 24 Right No No
5 Male 15 Left No Yes
6 Male 72 Right No No
7 Female 70 Right No No
8 Female 71 Left No No
9 Female 10 Right Yes Yes
10 Male 11 Right No No
11 Female 43 Left Yes Yes
12 Female 28 Right No No
13 Female 28 Left No No
14 Female 11 Right No No
15 Female 70 Right No No
16 Female 24 Right No No
17 Male 62 Right No No
18 Female 77 Right No No
19 Female 42 Right No No
20 Female 48 Right No Yes
21 Female 71 Left No No
22 Female 53 Right No Yes
23 Female 59 Right No No
24 Male 13 Right No No
25 Female 27 Right No No
26 Female 35 Left No Yes
27 Female 59 Left No No
28 Female 30 Right No No
29 Male 53 Right No No
30 Male 69 Right No Yes




Table 1: Population of study patients.
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number of implantees. It is clearly shown that only minute threshold 
decay with less than 5 dBHL loss is the most frequently found one, 
while prominent postoperative loss of hearing appears less often.
Subjects with complete loss of hearing following surgery
Nine implantees (9/30=30%) showed up with total loss of 
residual hearing at every measured frequency following surgery. 
Their preoperative hearing sensitivity is presented in Figure 6. It is 
clearly seen that within this subgroup of this cohort the measured 
average hearing threshold have been already poorer prior to surgery 
compared to those with preserved hearing. Genetic screening of 
the 30 recruited subjects revealed mutations in three cases in the 
background of hearing loss. All of these subjects suffered complete 
hearing loss postoperatively (3/3=100%), that genetic alteration 
may serve as a predictor when opting for an electro-acoustic/hybrid 
device, should be taken into consideration when indicating these 
systems [20].
Discussion
Preservation of acoustic hearing associated with cochlear 
implantation improves the postoperatively achievable periodicity 
and spectral resolution, which improves the patient's speech 
comprehension and the localization of the tone in particularly 
difficult conditions [21-26].
The effects of cochlear implantation on residual hearing have 
been discussed in several studies in which a number of surgical and 
technical factors have been identified [27]. There are some surgical 
techniques of approaching the scala tympani (i.e., RW, ERW, CS) 
with varying risks of harming the fine structures of the cochlea 
with prompt or delayed onset [13]. Such late complications, like the 
appearance of endocochlear connective tissue or new bone formation, 
may lead to a gradual partial or complete loss of residual acoustic 
hearing [28]. This is most likely to be seen when the round window 
is extendedly exposed, where endothelial lesions trigger new tissue 
proliferation. The slightest is the tendency to harm the endocochlear 
structures when minimally invasive, soft surgery is applied [13].
Physical attributes of the electrode profile may also interfere with 
postoperative cochlear function. Theoretically, the endocochlear 
hydrodynamics may also be altered, as the vibration of the basilar 
membrane is restricted due to the presence of an electrode array. At 
this point, as the travelling waves to the apical region are modified, 
the basilar membrane would react to sounds differently, leading to an 
endocochlear “conductive” hearing loss [29, 30].
The new type of thin-diameter electrode arrays close to the 
modiolus are expected to have a lower hydrodynamic load, since the 
bony spiral lamina is attached from below, thus the basilar membrane 
vibrations remain unrestricted. However, the perimodiolar position 
of the electrode array allows the adjacent nerve elements of the spiral 
ganglion to be stimulated with a lower electrical intensity and through 
a smaller surface.
Cadaver experiments demonstrated that a force, applied to the 
basilar membrane with an average of 88 mN (42 mN to 122 mN) 
would be sufficient to accomplish the interscalar dislocation of the 
electrode, of which manual perceptibility is questionable [31]. Studies 
with large case numbers (n=100) have shown that the probability 
of the electrode line being located in the scala vestibuli significantly 
increased during CS, which also manifested itself in the absence of 
improvement in speech comprehension [32].
In a number of studies, intraoperatively performed electro-
cochleography is used to track the electrode insertional trauma, 
furthermore to postoperative residual hearing follow-ups [33-35].
For the implementation of Electro-Acoustic (EAS) or hybrid 
speech processors the long-term preservation of residual acoustic 
hearing is inherently inevitable, thus application of atraumatic 
surgical techniques and electrode arrays is essential.
Our study cohort obviously demonstrates that by the application 
of appropriate soft surgery techniques and atraumatic electrodes are 
able to retain residual hearing on a long run. The positive experience 
gained with the new type of CI532 Slim Modiolar electrode predicts 
the possibility for the preservation of structural and functional 
integrity of all cochlear regions. Furthermore, a prompt, definitive 
solution could be provided for a possible late hearing loss progression, 
where only a psychophysical reprogramming of the implant would be 
enough.
On the basis of our results, if the acoustic hearing loss can be 
preserved with the assurance and efficacy of the initial experience, 
we will be able to provide sustained prominent hearing rehabilitation 
even in the indication of EAS that results in significant improvement 
in the life quality of many implantees.
In addition, long-term residual hearing loss may be of crucial 
importance in the subsequent feasibility of regenerative procedures 
and medical treatments [3,7,36,37].
Conclusion
In cochlear implantation, the use of new electrode array profiles 
plays a fundamental role in minimally invasive soft surgery, taking 
into individual needs, and providing long-term acoustic hearing 
preservation. Our study demonstrates the efficacy of the Nucleus 
CI532 Slim Modiolar electrode profile and it has the potential for 
granting residual hearing, which predicts the possible use of this 
configuration as part of EAS systems and makes it available for future 
treatments, i.e., the regeneration-based new therapeutic approaches 
of intracochlear hair-cells.
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